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A Gold- and Brønsted acid Catalytic Interplay Towards the Synthesis of 
Highly Substituted Tetrahydrocarbazoles 
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The reaction of indoles and stabilized cyclopropyl alkynes under gold- and/or gold & Brønsted acid-
catalysis provided access to highly substituted tetrahydrocarbazoles. A mechanistic study revealed 
the complex mechanism underlying these processes and the opportunistic cooperation of Lewis and 
Brønsted acid-catalysts towards the formation of complex molecular scaffolds.  
Keywords: Gold-catalysis • Cycloisomerization • Tetrahydrocarbazoles • Heterocycles • Brønsted 
Acid- catalysis 
 
Introduction 
Transition metal-catalyzed hydroarylations of C-C multiple bonds have attracted considerable 
attention as an efficient approach to functionalize arenes. The interest in this field has led to the 
development of a number of effective protocols for the hydroarylation of both alkenes[1,2] and 
alkynes.[2,3] Gold has played a preminent role in this context, acting as a Lewis acid to activate 
alkynes towards a variety of nucleophiles including arenes and heteroarenes among many others.[4] 
Indoles, being important motifs present in a large variety of bioactive molecules, have been already 
explored in these transformations. Thus, both Echavarren[5] and He’s groups[6] have developed 
methods where simple indoles react intermolecularly with terminal alkynes in the presence of 
cationic gold(I) and gold(III) complexes respectively, affording bisindolyl derivatives (Scheme 1, eq. 
1). Allenes could also be used as reaction counterparts in the presence of a platinum catalyst 
(Scheme 1, eq. 2).[7] Intramolecular versions of these transformations have also been studied:[5] C3-
substituted indoles react with alkynes in the presence of gold catalysts to give 7- and 8-membered 
rings in a process controlled by the oxidation state of the catalyst (Scheme 1, eq. 3). A highly efficient 
synthesis of substituted tetrahydrocarbazoles from pent-4-ynal and indoles using silver(I) catalysts 
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has also been recently reported (Scheme 1, eq. 4).[8] The formation of tetrahydrocarbazole 
derivatives via gold-catalyzed intermolecular cycloadditions between 2-vinylindoles and different 
dienophiles such as N-allenamides[9], conjugated esters[10] and propargylic esters has also been 
established (Scheme 1, eq. 5-7).[11]  Additional developments in this field are granted given the 
presence of tetrahydrocarbazole blueprints in many natural products and pharmaceuticals.[12] 
 
Scheme 1. Gold-,  platinum- and silver-catalyzed synthesis of indolyl derivatives  
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Based on our going interest in the use of gold to streamline the synthesis of valuable building blocks 
via multicomponent reactions,[13] we decided to investigate the formation of highly substituted 
carbocycles using indoles 2 and stabilized cyclopropyl alkynes 1 as potential reaction partners 
(Scheme 2). Cyclopropyl rings are privileged motifs towards the construction of molecular 
complexity[14] and in combination with alkynes and gold catalysis can offer access to previously 
unknown molecular assemblies.[15] 
 
Scheme 2. This work 
 
 
 
Results and Discussion 
The reaction of 1-(2-ethynylcyclopropyl)-4-methoxybenzene (1a) with different N-protected indoles 
2 in the presence of various gold catalysts was used to find the optimal conditions (Table 1). When 
1a was combined with N-benzyl protected indole (2a) no conversion or only traces of the desired 
products 3a and 3’a were observed using gold catalysts either bearing σ-donor such as IPr (1,3-
bis(2,6-diisopropylphenyl)imidazol-2-ylidene), Ph3P ot (tBu)3P, or π-acceptor (phosphite) ligands 
(Table 1, entries 1-5). The use of cationic gold complex 4[16] in toluene, afforded complete conversion 
of the starting materials into tetrahydrocarbazoles 3a and 3’a (Table 1, entry 6). The reaction was 
regioselective favoring tetrahydrocarbazole 3a over 3’a in a 6:1 ratio. Both 3a and 3’a where isolated 
in high yield as an unseparable 2:1 mixture of diastereoisomers. The same conditions were applied 
to N-methyl indole (2b) which produced a 2:1 ratio of regioisomers 3b and 3’b in 60% yield (entry 7). 
Upon heating the reaction mixture to 80 oC a 4:1 regioisomeric mixture of the corresponding 
tetrahydrocarbazoles was obtained in 88% yield (entry 8). Having established cationic gold complex 
4 as catalyst, we decided to apply these reaction conditions to non-protected indole (2c). Using 4 in 
toluene, dichloromethane and 1,2-dichloroethane as solvents, the reaction showed no conversion to 
products 3c and 3’c even after prolongued stirring and heating (entries 9-11). Reaction in dry THF at 
100 oC afforded a 1:1 mixture of regioisomers 3c and 3’c which could be isolated in 92% yield (entry 
12). 
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Table 1. Optimization of Reaction conditions.a,b 
 
 
Entry R1 Conditions Yieldc / regioisomeric ratio 3:3’ / (d. r.) d 
1 Bn (2a) IPrAuNTf2,e CH2Cl2, 25oC, 48 h No reaction 
2 Bn (2a) Ph3PAuNTf2, CH2Cl2, 25oC, 48 h Traces 
3 Bn (2a) (t-Bu)3PAuNTf2, CH2Cl2, 25oC, 48 h Traces 
4 Bn (2a) (PhO)3PAuSbF6, CH2Cl2, 25oC, 3 h Traces 
5 Bn (2a) (PhO)3PAuSbF6, CH2Cl2, 50oC, 72 h Traces 
6 Bn (2a) 4,Toluene, 25oC, 24 h 95 / 6:1 / (2:1) 
7 Me (2b) 4,Toluene, 25oC, 24 h 60 / 2:1 / (2:1) 
8 Me (2b) 4,Toluene, 80oC, 12 h 88 / 4:1 / (2:1) 
9 H  (2c) 4, Toluene, 25oC, 24 h No reaction 
10 H  (2c) 4, CH2Cl2, 25oC, 24 h No reaction 
11 H  (2c) 4, 1,2-C2H4Cl2, 80oC, 24 h No reaction 
12 H  (2c) 4,THF, 100oC, 12 h 92 / 1:1 / (1:1) 
a
 Reaction [0.1M ].  b Major diastereoisomer depicted.  c Isolated yield after column chromatography. d d.r.: diastereomeric  ratio measured in the 
crude 1H-NMR for both major (3) and minor (3’) regioisomers. e IPr: 1,3-bis(2,6-diisopropylphenyl)imidazol-2-ylidene. 
 
 
With the best conditions in hand, using catalyst 4 in toluene at 80oC for N-protected indoles and THF at 100 oC for non-
protected ones, we then set out to explore the scope of this transformation (Table 2). The reaction tolerates different groups at 
the nitrogen atom as well as at the C5-position of the indole counterpart, thus yielding the corresponding tetrahydrocarbazoles 
3a-b/3’a-b, 3d-m/3’d-m in 42-95% with regioselectivities up to 10:1 (entries 1-12). The scope of the reaction was expanded to 
different cyclopropyl alkynes bearing substituents able to stabilize the positive electron density developed during the 
cyclopropyl-ring-opening process. Alkynes 1b-1d reacted with N-benzyl or N-methyl indoles affording products 3n-p/3’n-p and 
3q-r/3’q-r respectively (entries 13-17). An additional substituent at position 2 of the cyclopropyl ring was also tolerated (1d) 
affording the desired products 3s-t/3’s-t in good yields (entries 18-19). In these cases, the tetrahydrocarbazoles were obtained 
as 5:1 to 1:1 mixtures of diastereoisomers under the standard reaction conditions. Noticing the variability of diastereomeric 
mixtures observed throughout these series, we then decided to run the reaction in the presence of base in order to check its 
influence in the selectivity of the process (Table 2, last column). Recently, examples of Brønsted acid catalysis initially assigned 
to gold organometallic catalysis have been reported.[17] Remarkably, in all cases, the ratio between the regioisomers 3 and 3’ 
improved by the addition of 0.5 or 1.0 equivalents of NaHCO3. However, no change in the diastereoselectivity of the reaction 
was observed. 
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Table 2. Scope of gold-catalyzed cycloisomerization of 1-cyclopropyl-alkynes.  
 
 
Entry 
 
Alkyne 
 
 X 
 
R1 
 
Product 
 
Yielde / regioisomeric ratio 3:3’ / (d. r.) No 
base Yield
e / regioisomeric ratio 3:3’ / (d. r.) Base 
1 1a  H Bn (2a) 3a 95 / 6:1a / (2:1) 83 / 12:1c / (2:1) 
2 1a  H Me (2b) 3b 88 / 4:1a / (2:1) 74 / 6:1d / (2:1) 
3 1a  H PMBf (2d) 3d 76 / 7:1a / (2:1) 63 / 7:1c / (2:1) 
4 1a  H Cynnamyl (2e) 3e 78 / 10:1a (2:1) - 
5 1a  H C5H11 (2f) 3f 79 / 6:1a / (2:1) 75 / 6:1d / (2:1) 
6 1a  OMe Me (2g) 3g 86 / 2:1a / (2:1) 54 / 2:1d / (2:1) 
7 1a  OMe Bn (2h) 3h 56 / 3:1a / (2:1) 60 / 3:1c / (2:1) 
8 1a  Br Me (2i) 3i 72 / 8:1a / (2:1) 73 / 8:1d / (2:1) 
9 1a  Br Bn  (2j) 3j 68 / 5:1a / (2:1) 76 / 7:1c / (2:1) 
10 1a  Me Me  (2k) 3k 84 / 5:1a / (2:1) 77 / 7:1d / (2:1) 
11 1a  Me Bn  (2l) 3l 42 / 3.5:1a / (2:1) 45 / 5:1c / (2:1) 
12 1a  CN Me  (2m) 3m 52 / 2:1a / (2:1) 45 / 5:1d / (2:1) 
13 1b  H Bn (2a) 3n 81 / 5:1a / (1:1) 70 / 5:1c / (1:1) 
14 1b  CN Me  (2m) 3o 79 / 7:1a / (5:1) 34 / 7:1d / (5:1) 
15 1b  Br Me (2i) 3p 82 / 5:1a / (1:1) 80 / 12:1d / (1:1) 
16 1c  H Bn (2a) 3q 57 / 5:1a / (1:1) - 
17 1c  Br Me (2i) 3r 69 / 5:1a / (1:1) - 
18 1d  H Bn (2a) 3s 63 / 5:1a / (1:1) 70 / 8:1c / (1:1) 
19 1d  H Me (2b) 3t 63 / 5:1a / (1:1) 56 / 6:1d / (1:1) 
20 1a  H H (2c) 3c 92 / 1:1b / (1:1) - 
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21 1a  Br H (2n) 
22 1a  Me H (2o) 
23 1a  CN H (2p) 
a
 Reaction conditions: Toluene [0.1M], 4 (5 mol%), 80°
Toluene [0.1M], 4 (5 mol%), NaHCO3 (1.0 eq.), 80°C, 
eIsolated yield after column chromatography.  f  PMB: 4
 
The scope of the reaction was furthe
reaction of N-protected indoles, thes
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2, entries 20-23). The structure of the
diffraction analysis on compounds 3i 
 
Figure 1. X-Ray diffraction analysis of compounds 3i and 3’
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Scheme 3. Regioselective synthesis of 5 and 6.  
 
 
Control experiments were designed taking into account the possibility of both a gold- or a Brønsted-
acid-catalysis (Scheme 4). First, the reaction between 1a and N-benzyl or N-methyl indole 2a-b was 
performed in the presence of different amounts of protic acids. Using catalytic amounts of 
trifluoroacetic acid (TFA, 10 mol%) allene 6 was detected although no total conversion could be 
achieved despite of prolonged heating (data not shown). In contrast, the reaction with 
substoichiometric amounts of TFA (80 mol%) afforded allenes 6a-b in good yields (Scheme 4A). 
These reactions do not evolve into the tetrahydrocarbazoles products, confirming that the overall 
transformations cannot be fully Brønsted-acid-catalyzed processes. To confirm this hypothesis 
isolated allene 6b was exposed to acidic conditions. In the presence of catalytic (10 mol%) and 
substoichiometric (80 mol%) amounts of TFA no conversion was observed, even in the presence of 1 
equivalent of methyl indole 2b (Scheme 4B). In contrast, the reaction of 6b in the presence of 5 
mol% of gold catalyst 4 (Scheme 4C) afforded total conversion to carbazole 7b as a 2:1 regioisomeric 
mixture of exo and endo alkenes after one hour of reaction.  
The fact that 7b cannot be formed by protic acid confirms that the gold catalyst is indeed needed in 
these transformations.[5,6] Interestingly, the reaction of the allenyl intermediates 6a-b in presence of 
one equivalent of the corresponding indoles 2a-b and the gold catalyst 4 afforded  
tetrahydrocarbazoles 3a and 3b as single regioisomers in 60% to 82% yield as a 2:1 mixture of 
diastereoisomers (Scheme 4D).  
 
Scheme 4. Acid-catalyzed synthesis of allenes 6a-b and gold-catalyzed formation of 7b and 3a-b.a 
N
R1
MeO
+
(1.0 eq.) (1.0 eq.)
TFA (80 mol%)
Toluene, 80oC
12 h
N
R1
MeO
6a, (60% yield)
6b, (76% yield)
1a
Toluene, 80oC
12 h
TFA (10 mol%)
to (80 mol%)
S. M.
Toluene, 80oC
12 h
TFA (10 mol%)
to (80 mol%)
S. M.
2b, (1.0 eq.)
6b
4 (5 mol%)
Toluene, 80oC
1 h
N
OMe
7b, (89% yield)
Toluene, 80°C
12 h
N
N
R1
R1
OMe
R1 = Bn, 3a, (2:1 d.r.), (82% yield)
Me, 3b, (2:1 d.r.), (60% yield)
6b 6a-b
4 (5 mol%)
2 (1.0 eq.)
A. B.
C. D.
H
2a, R1 = Bn
2b, R1 = Me
 
a HCl and p-TsOH were also used. 
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The ability of carbazole 7 to produce tetrahydrocarbazoles 3 was investigated next (Scheme 5). First, 
the reaction of 7b in the presence of 10 and 80 mol% of TFA and one equivalent of methyl indole 
(2b) delivered the corresponding tetrahydrocarbazole 3b as single regioisomer in 6:1 and 2:1 
diastereomeric ratios, respectively (Scheme 5A). In contrast, the reaction in the presence of catalytic 
amounts of gold complex 4 afforded 3b in 79% yield in a 2:1 diastereomeric ratio (Scheme 5B). The 
discrepancy with previous results, where final products were usually obtained as 2:1 diastereomeric 
mixtures (Table 2), prompted us to think about the possibility of acid- or gold-catalyzed 
epimerization reaction at the benzylic position of the products. To validate this hypothesis, a 6:1 
diastereomeric mixture of the tetrahydrocarbazole 3b was treated with 80 mol% of acid (Scheme 
5C1). After 12 hours at room temperature, epimerization at the benzylic position of the 
tetrahydrocarbazole 3b was observed affording a 2:1 diastereomeric mixture. Gold was also able to 
epimerize the benzylic position of 3b (Scheme 5C2) from a diastereomeric ratio of 6:1 to 4:1. 
However, when 1 equivalent of NaHCO3 was used (Scheme 5D) no epimerization was observed, thus 
confirming that acid is needed to promote the corresponding isomerization at the benzylic position. 
 
Scheme 5. Acid- and gold-catalyzed synthesis of tetrahydrocarbazole 3b and epimerization experiments. 
 
 
As shown in Scheme 4, experiments with allene 6 in presence of acid and gold catalyst 4 could not 
explain the formation of the observed minor regioisomer 3’. Thus, we hypothesized that 3’ could be 
formed as a result of the direct attack of the indole to the alkyne moiety via vinyl cyclopropyl 
intermediate 5 (Scheme 3). 5 was synthetized independently and submitted to both gold and 
Brønsted acid catalysis (Scheme 6). The reaction with 5 mol% of 4 afforded different regioisomeric 
mixtures of carbazoles 7 and 7’ (Scheme 6, eq. 1). On the other hand, the reaction of 5b in the 
presence of catalytic amounts of TFA afforded a 1:1 mixture of carbazoles 7b and 7’b (Scheme 6, eq. 
2). Intermediate 5b was also exposed to catalytic (10 mol%) and substoichiometric amounts (80 
mol%) of TFA in the presence of indole 2b, affording in both cases a 1:1 regioisomeric mixture of 
tetrahydrocarbazoles 3b and 3’b (Scheme 6, eq. 3). Interestingly, the reaction of 5b in the presence 
of 5 mol% of the gold catalyst 4 afforded a 4:1 regioisomeric mixture of 3b and 3’b which could be 
isolated in 71 and 15% yields, respectively (Scheme 6, eq. 4). 
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Scheme 6. Reactivity of intermediate 5. 
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TFA (10 mol% or
80 mol%)
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4 (5 mol%)
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80oC, 12 h
2b (1.0 eq.)
2b (1.0 eq.)
10 mol%: 3b:3'b, 1:1 regio. ratio, (24% yield)
80 mol%: 3b:3'b, 1:1 regio. ratio, (99% yield)
3b:3'b, 4:1 regio. ratio, (2:1 d.r.),
(3b 71% yield, 3b' 15% yield)
N
N
N N
3'b
+
OMe
MeO
3b
N
N
N N
3'b
+
OMe
MeO
3b
H
H
(eq. 1)
(eq. 2)
(eq. 3)
R1 = Me
(eq. 4)
 
 
 
 
The formation of tetrahydrocarbazoles 3b and 3’b described in Scheme 6 can thus be explained via 
carbazoles 7 and 7’ respectively. For this reason one last set of experiments was designed in order to 
study this final step. A 6:1 regioisomeric mixture of intermediates 7a and 7’a was reacted with one 
equivalent of benzyl indole 2a in the presence of catalytic amounts of gold catalyst 4 (Scheme 7). 
The reaction afforded a 6:1 regioisomeric mixture of the desired products 3a and 3’a. The same 
regioselective pattern was observed for intermediates 7b and 7’b, which provided a 4:1 
regioisomeric mixture of 3b and 3’b (Scheme 7, eq. 1). The selectivity observed in this 
transformation as well as the regioselectivity observed in the formation of intermediates 7b and 7’b 
(Scheme 6) is in agreement with the results observed for the reaction between methyl indole and 
the corresponding alkyne 1a under the standard reactions conditions (Table 1, entry 8). Moreover, 
the reaction of intermediate 8 in presence of one equivalent of methyl indole afforded the 
tetrahydrocabazol 9 in 82% yield as a single regioisomer (Scheme 7, eq. 2). 
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Scheme 7. Gold-catalyzed synthesis of products 3/3’ from intermediates 7/7’. 
 
 
 
A complete mechanistic picture[18] involving three main steps can be formulated using the collected data (Scheme 8). First, both gold and 
acid can catalyze the formation of intermediates 5 and 6 in a regio-divergent process. Gold-coordination to alkyne 1a triggers the 
nucleophilic attack of indole 2 delivering vinyl cyclopropyl intermediate 5 (Scheme 8, blue). 5 can then be activated in the presence of both 
gold and/or acid triggering a cyclopropyl-ring opening to form 1,5-dipole 10, which cyclizes to afford the  spirocyclic intermediate 11.[19] A 
subsequent ring expansion delivers regioisomeric mixtures of carbazoles 7 and 7’. Further gold- or protic acid-activation of the double 
bond in 7 and 7’ followed by nucleophilic attack of a second molecule of indole afford the corresponding tetrahydrocarbazoles 3 and 3’. 
Alternatively, Brønsted acid can activate the alkyne triggering the nucleophilic attack of the indole onto C2 of the cyclopropyl ring to 
produce allene 6 (Scheme 8, red). Then, after gold activation of the allene 6, the intramolecular attack of the indole delivers spirocyclic 
intermediate 11,[19] which selectively isomerizes to form 7 first, and regioisomer 3 thereafter. 
 
Scheme 8. Mechanistic proposal.  
 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
Conclusions 
This work describes the reactivity of 1-ethynylcyclopropyl derivates and indoles under gold catalysis. 
Highly substituted tetrahydrocarbazoles were obtained in good yields. The regioselectivity of the 
process is significant for N-protected indoles and  can be improved in the presence of stoichiometric 
amounts of base. We have proposed that traces of acid produced in situ in the reaction mixture play 
a critical role in the selectivity of the cycloisomerization of the spyrocyclic intermediates to form the 
corresponding tetrahydrocarbazole products. We also demonstrated that the formation of the 
tetrahydrocarbazole products can be explained via gold-catalysis and/or via combination of gold- 
and protic acid-catalysis. A plausible reaction mechanism, where both gold and acid are involved, 
seem to be signalized by different control experiments performed, thus highlighting the mechanistic 
diversity of gold catalyzed reaction and the hitherto possibility of coexisting reaction pathways 
towards the observed  reaction outcomes. 
 
Experimental Section 
General Informations 
All reactions were carried under non-inert atmosphere. All reagents were used as received unless 
otherwise noted. Solvents were purchased in HPLC quality, degassed by purging thoroughly with 
nitrogen and dried over activated molecular sieves of appropriate size. Alternatively, they were 
purged with argon and passed through alumina columns in a solvent purification system (Innovative 
Technology). Reactions were monitored by thin layer chromatography (TLC) using Merck TLC silica 
gel 60 F254. Flash column chromatography was performed over silacycle silica gel (230-400 mesh). 
NMR spectra were recorded on AV2 400 or AV2 500 MHz Bruker spectrometers. Chemical shifts are 
given in ppm. The spectra are calibrated to the residual 1H and 13C signals of the solvents. 
Multiplicities are abbreviated as follows: singlet (s), doublet (d), triplet (t), quartet (q), doublet-
doublet (dd), doublet-doublet-doublet (ddd), quintet (quint), septet (sept), multiplet (m), and broad 
(br). Infrared spectra were recorded on a JASCO FT/IR-4100 spectrometer. High-resolution 
electrospray ionization mass spectrometry was performed on a Finnigan MAT 900 (Thermo Finnigan, 
San Jose, CA; USA) doublefocusing magnetic sector mass spectrometer 10 spectra were acquired. A 
mass accuracy ≤ 2 ppm was obtained in the peak matching acquisition mode by using a solution 
containing 2 <l PEG200, 2 <l PPG450, and 1.5 mg NaOAc (all obtained from Sigma-Aldrich, CH-Buchs) 
dissolved in 100ml MeOH (HPLC Supra grade, Scharlau, E-Barcelona) as internal standard. 
The separation of regioisomers 3/3‘ was not always possible. Regioisomeric and diastereoisomeric 
ratios have been calculated from the crude 1H NMR mixture and the individual analytical data are 
described herein only when the isolation was possible. 
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Experimental procedure for the preparation of cyclopropyl alkynes 1a-1d 
 
 
1) To a solution of NaH (1.05 eq.) in THF (0.8 M) at 0°C, triethyl phosphonoacetate (1.1 eq.) was 
added dropwise. The mixture was stirred at 0°C for 20 minutes. Then, the carbonyl compound (1.0 
eq.) was added dropwise at 0°C. The reaction was stirred at 25°C for 12 hours and quenched with 
brine. Approximately 2/3 of the solvent was evaporated under reduced pressure. The aqueous layer 
was extracted with CH2Cl2 (2 times) and the combined organic layers were dried over Na2SO4. The 
solvent was evaporated under reduced pressure and the residue was purified by column 
chromatography on silica gel (pentane) to give the corresponding α,β-unsaturated ester in 82-95% 
yield. 
2) To a solution of NaH (1.05 eq.) in THF (0.6 M) at 25°C, trimethylsulfoxonium iodine (1.15 eq.) was 
added as a solid in small portions. The mixture was stirred for 1 hour before a solution of the 
corresponding ester (1.0 eq.) in DMSO (1.0 M) was added. The mixture was stirred at room 
temperature for 12 hours. The reaction was quenched with brine and extracted with diethyl ether (3 
times). The organic layers were dried over Na2SO4. Solvent was evaporated under reduced pressure 
and the residue was purified by column chromatography on silica gel (pentane) to give the 
corresponding cyclopropyl ester in 62-90% yield. 
3) To a solution of the corresponding cyclopropyl ester (1.0 eq.) in CH2Cl2 (0.2 M) at -78°C, DIBAL (1.0 
M in hexane, 2.2 eq.) was added dropwise. The reaction was stirred at -78°C for 1 hour. The reaction 
was quenched with ethyl acetate (3 eq.) and diluted with diethyl ether. A saturated solution of Na/K-
tartrate was added to the mixture and the reaction was stirred for another 3 hours till clear 
separation of the two phases was observed. The aqueous layer was extracted with diethyl ether and 
the combined organic layers were dried over Na2SO4. The solvent was evaporated under reduced 
pressure and the residue was purified by column chromatography on silica gel (hexane:ethyl acetate 
4:1) to give the corresponding alcohol in 60-90% yield. 
4) To a solution of oxalyl chloride (1.5 eq.) in CH2Cl2 (0.4 M), DMSO (2.3 eq.) was added dropwise. 
The reaction was stirred at -78°C for 1 hour. Then, the corresponding alcohol (1.0 eq.) was added 
dropwise in CH2Cl2 (1.4 M). The reaction was stirred at -78°C for 1 hour, and triethylamine (5.0 eq.) 
was added dropwise. The reaction was stirred at -78°C for another hour. The mixture was then 
warmed up to room temperature for another 30 minutes and quenched with a saturated solution of 
ammonium chloride. The aqueous layer was extracted with CH2Cl2 and the combined organic layers 
were dried over Na2SO4. The solvent was evaporated under reduced pressure. The crude product 
was used in the next step without further purification. 
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5) To a solution of CBr4 (2.2 eq.) in CH2Cl2 (1.5 M) at 0°C, a solution of triphenylphosphine (4.4 eq.) in 
CH2Cl2 (1.5 M) was added dropwise. The resulting dark orange solution was stirred for 5 minutes. A 
solution of the corresponding cyclopropylaldehyde (1.0 eq.) dissolved in CH2Cl2 (1.0 M) was added 
dropwise. The solution was stirred at 0°C for 2-3 hours. The reaction mixture was quenched by 
addition of water. The aqueous layers where extracted with CH2Cl2. The combined organic layers 
were washed with water and brine. The organic layer was dried over MgSO4 and the crude was 
purified by column chromatography on silica gel (hexane) to yield the dibromo derivatives in 65-80% 
yield. 
6) To a solution of the corresponding cyclopropyl-dibromo derivate (1.0 eq.) in THF (0.2 M) at -78°C, 
nBuLi (1.0 M in hexane, 2.0 eq.) was added dropwise. The solution was stirred at -78°C for 3 hours 
and then warmed up to room temperature for 20 minutes. The resulting solution was cooled down 
to -78°C and water (1.05 eq.) was added dropwise. The reaction was stirred at room temperature for 
12 hours. Water was added and the aqueous layer was extracted with EtOAc. The organic layers 
were dried over Na2SO4 and the crude was purified by column chromatography on silica gel 
(Hexane:EtOAc 25:1) to give the corresponding propargyl alcohol in 33-93% yield. 
 
Analytical data for representative cyclopropyl alkynes 
 
1-(2-Ethynylcyclopropyl)-4-methoxybenzene 1a 
IR (neat, ν/cm-1): 3290, 3004, 2937, 2832, 1612, 1515, 1463, 1288, 1246, 1180, 1034, 827, 806, 674, 569; 1H NMR (400 MHz, 
CDCl3): δ = 7.06-6.94 (m, 2H), 6.84-6.78 (m, 2H), 3.78 (s, 3H), 2.24 (ddd, J = 8.8, 6.1 Hz, 1H), 1.89 (d, J = 2.1 Hz, 1H),  1.47-
1.37 (m, 1H), 1.31-1.24 (m, 1H), 1.22-1.12 (m, 1H) ppm; 13C NMR (100 MHz, CDCl3): δ 158.4, 132.6, 127.3, 114.0, 86.6, 64.7, 
55.4, 25.6, 17.1, 10.5 ppm; HRMS (ESI): m/z: calcd for C12H13O+: 173.09609, found: 173.09627. 
 
(2-(2-Ethynylcyclopropyl)prop-1-en-1-yl)benzene 1b 
IR (neat, ν/cm-1): 2970, 1738, 1513, 1439, 1375, 1231, 1240, 1066, 1054, 894, 834, 696, 667, 571; 1H NMR (400 MHz, CDCl3): 
δ = 7.31 (t, J = 7.6 Hz, 2H), 7.24-7.14 (m, 3H), 6.35 (s, 1H), 1.93 (dt, J = 8.7, 5.7 Hz, 1H), 1.88 (d, J = 2.0 Hz, 1H),  1.77 (s, 3H), 
1.42 (tdt, J = 6.9, 5.1, 1.9 Hz, 1H), 1.19-1.00 (m, 2H) ppm; 13C NMR (100 MHz, CDCl3): δ 138.0, 136.4, 128.97, 128.96, 128.2, 
126.3, 125.4, 86.8, 64.6, 30.7, 15.8, 14.5, 7.1 ppm; HRMS (EI): m/z: calcd for C14H14+: 182.10955, found: 182.10689. 
 
1-(2-Ethynyl-1-methylcyclopropyl)-4-methoxybenzene 1d 
IR (neat, ν/cm-1): 3291, 2113, 1702, 1643, 1598, 1492, 1443, 1378, 1223, 1202, 1173, 1119, 1074, 1056, 1029, 953, 942, 918, 
844, 780, 739, 698, 648, 600, 508, 492; 1H NMR (400 MHz, CDCl3): δ = 7.22-7.17 (m, 2H), 6.85-6.80 (m, 2H), 3.78 (s, 3H), 
1.98 (d, J = 2.2 Hz, 1H), 1.58 (ddd, J = 8.9, 5.6, 2.2 Hz, 1H),  1.52 (s, 3H), 1.33 (dd, J = 9.0, 4.5, 1H), 0.90 (dd, J = 5.5, 4.6, 1H) 
ppm; 13C NMR (101 MHz, CDCl3) δ 158.1, 137.7, 128.5, 113.8, 84.8, 67.0, 55.3, 26.8, 22.9, 22.6, 14.7 ppm; HRMS (ESI): m/z: 
calcd for C13H15O+: 187.11174, found: 187.11186. 
 
Experimental procedure for tetrahydrocarbazols 3 and 3’ 
 [{(2-Biphenyl)di-tBu-phosphine}Au(CH3CN)]SbF6 (0.0058 mmol, 0.05 eq.) was added to a solution of 
the corresponding indol (0.232 mmol, 2.0 eq.) and the cyclopropyl alkyne (0.116 mmol, 1.0 eq.) in 
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toluene (0.1M). The mixture was stirred at 80 oC for 12 h. Then, Et3N (0.05 eq.) was added to the 
reaction. The mixture was evaporated in vacuum and the residue was purified by flash 
chromatography (Hexane:EtOAc) affording the corresponding tetrahydrocarbazol in 42-92% yield. 
 
Experimental procedure for tetrahydrocarbazols 3 and 3’ with base 
[{(2-Biphenyl)di-tBu-phosphine}Au(CH3CN)]SbF6 (0.0058 mmol, 0.05 eq.) was added to a solution of 
the corresponding indol (0.232 mmol, 2.0 eq.), the cyclopropyl alkyne (0.116 mmol, 1.0 eq.) and 
NaHCO3 (0.5-1.0 eq.) in toluene (0.1M). The mixture was stirred at 80 oC for 12 h. Then, Et3N (0.05 
eq.) was added to the reaction. The mixture was evaporated in vacuum and the residue was purified 
by flash chromatography (Hexane:EtOAc) affording the corresponding tetrahydrocarbazol in 34-83% 
yield. 
 
9-Benzyl-4-(1-benzyl-1H-indol-3-yl)-1-(4-methoxyphenyl)-4-methyl-2,3,4,9-tetrahydro-1H-carbazole (3a) 
Obtained as 2:1 diastereomeric mixture. Characterization of a 1:0.70 diastereomeric ratio. IR (neat, 
ν/cm-1): 3028, 2929, 2852, 1605, 1507, 1455, 1356, 1321, 1240, 1176, 1037, 835, 736, 695, 562; 1H 
NMR (400 MHz, CDCl3): δ = 7.77 (d, J = 8.1 Hz, 1H, minor isomer), 7.65 (d, J = 8.0 Hz, 1H, major 
isomer), 7.53-7.48 (m, 1H, major and minor isomer), 7.28-6.80 (m, 20H major isomer and 19H minor 
isomer), 6.68 (d, J = 8.7 Hz, 2H, minor isomer), 6.59 (s, 1H, major isomer), 5.31-5.12 (m, 3H, major 
and minor isomer), 4.76 (d, J = 17.0 Hz, 1H, major and minor isomer), 4.02-3.97 (m, 1H, major and 
minor isomer), 3.80 (s, 3H major isomer), 3.75 (s, 3H, minor isomer), 2.46-2.42 (m, 1H, minor 
isomer), 2.40-2.34 (m, 1H, major isomer), 2.30-2.20 (m, 1H, minor isomer), 2.14 (s, 3H, major 
isomer), 2.12-2.07 (m, 1H, major isomer), 2.06 (s, 3H, minor isomer), 2.03-1.99 (m, 1H, minor 
isomer), 1.96-1.89 (m, 1H, major isomer), 1.83-1.76 (m, 1H, minor isomer), 1.74-1.68 (m, 1H, major 
isomer) ppm; 13C NMR (100 MHz, CDCl3) (major and minor isomer): δ = 158.2, 158.1, 138.4, 138.3, 
138.1, 137.9, 137.6, 137.5, 137.5, 136.5, 136.4, 136.2, 136.1, 129.1, 128.8, 128.6, 128.6, 128.6, 
128.5, 127.8, 127.5, 127.3, 127.2, 127.0, 126.9, 126.5, 126.4, 126.3, 126.0, 125.9, 124.1, 123.3, 
121.4, 121.3, 121.2, 121.1, 121.0, 120.9, 120.8, 119.5, 119.3, 118.7, 118.6, 118.4, 113.8, 109.9, 
109.8, 109.3, 109.2, 55.2, 55.2, 49.7, 49.6, 46.5, 46.3, 38.9, 38.1, 36.7, 36.4, 34.6, 31.3, 30.4, 29.0, 
28.1 ppm; MS (ESI): m/z (M+): 609.4. 
 
1-(4-Methoxyphenyl)-4,9-dimethyl-4-(1-methyl-1H-indol-3-yl)-2,3,4,9-tetrahydro-1H-carbazole (3b) 
Obtained as 2:1 diastereomeric mixture. Characterization of a 1:0.50 diastereomeric ratio. IR (neat, 
ν/cm-1): 3048, 2921, 2840, 1611, 1509, 1467, 1370, 1244, 1176, 1089, 1031, 907, 835, 731, 562; 1H 
NMR (400 MHz, CDCl3): δ = 7.75 (d, J = 8.0 Hz, 1H, major isomer), 7.70 (d, J = 7.9 Hz, 1H, minor 
isomer), 7.54 (d, J = 7.9 Hz, 1H, major isomer), 7.42 (d, J = 7.9 Hz, 1H, minor isomer), 7.31 (d, J = 8.2 
Hz, 1H, major isomer), 7.27 (d, J = 8.5 Hz, 1H, major isomer), 7.19 (t, J = 7.6 Hz, 2H, major isomer), 
7.17-7.13 (m, 2H, minor isomer), 7.08-7.05 (m, 1H major isomer and 2H minor isomer), 7.02-6.98 (m, 
2H major isomer and 3H minor isomer), 6.94 (t, J = 7.5 Hz, 1H, minor isomer), 6.83 (d, J = 8.6 Hz, 2H, 
major isomer), 6.79 (d, J = 8.7 Hz, 2H, minor isomer), 6.72 (s, 1H, minor isomer), 6.33 (s, 1H, major 
isomer), 4.22-4.18 (m, 1H, major and minor isomer), 3.79 (s, 3H, major isomer), 3.76 (s, 3H, minor 
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isomer), 3.67 (s, 3H, minor isomer), 3.58 (s, 3H, major isomer), 3.99 (s, 3H, major isomer), 3.35 (s, 
3H, minor isomer), 2.43-2.26 (m, 2H, major isomer), 2.14-2.05 (m, 2H, minor isomer), 2.10 (s, 3H, 
major isomer), 1.99 (s, 3H, minor isomer), 1.97-1.79 (m, 1H major isomer and 2H minor isomer), 
1.73-1.69 (m, 1H, major isomer) ppm; 13C NMR (100 MHz, CD2Cl2) (major and minor isomer): δ = 
158.1, 158.0, 138.0, 137.9, 137.4, 136.8, 136.6, 136.2, 136.1, 129.1, 128.9, 128.8, 127.8, 126.3, 
126.1, 125.8, 123.3, 122.3, 121.3, 121.2, 121.1, 121.0, 120.8, 120.7, 120.5, 120.4, 118.8, 118.6, 
118.4, 118.3, 118.1, 118.0, 113.9, 113.7, 109.3, 109.2, 108.6, 108.5, 55.2, 39.0, 37.8, 36.8, 36.5, 36.5, 
33.9, 32.6, 32.5, 31.2, 29.9, 29.8, 29.4, 29.3, 28.1 ppm; HRMS (ESI): m/z: calcd for C30H30N2NaO+: 
457.2250, found: 457.2247. 
 
4-(4-Methoxyphenyl)-1,9-dimethyl-1-(1-methyl-1H-indol-3-yl)-2,3,4,9-tetrahydro-1H-carbazole (3’b),  
minor diastereoisomer 
Obtained as 2:1 diastereomeric mixture. IR (neat, ν/cm-1): 3043, 2931, 2846, 2249, 1610, 1508, 1468, 
1364, 1324, 1240, 1173, 1035, 1015, 906, 829, 727, 647, 567; 1H NMR (400 MHz, CDCl3): δ = 7.28-
7.26 (m, 1H), 7.20 (d, J =  8.3 Hz, 2H), 7.15-7.12 (m, 2H), 7.07 (t, J = 7.4 Hz, 1H), 6.88-6.84 (m, 7H), 
4.32 (dd, J = 8.2, 5.6 Hz, 1H), 3.81 (s, 3H), 3.78 (s, 3H), 3.30 (bs, 3H), 2.43-2.37 (m, 1H), 2.19-2.12 (m, 
1H), 1.98 (s, 3H), 1.93-1.88 (m, 2H) ppm; 13C NMR (100 MHz, CDCl3): δ = 157.9, 142.1, 138.7, 137.7, 
137.5, 129.2, 126.4, 126.3, 126.0, 125.8, 121.4, 120.5, 120.5, 119.9, 119.0, 118.4, 113.6, 111.6, 
109.1, 108.5, 55.2, 40.6, 40.4, 35.8, 32.7, 32.3, 30.7, 26.9 ppm; MS (ESI): m/z [M+Na]+: 457.2. 
 
4-(4-Methoxyphenyl)-1,9-dimethyl-1-(1-methyl-1H-indol-3-yl)-2,3,4,9-tetrahydro-1H-carbazole (3’b),  
major diastereoisomer 
Obtained as 2:1 diastereomeric mixture. IR (neat, ν/cm-1): 3043, 2931, 2846, 2249, 1610, 1508, 1468, 
1364, 1324, 1240, 1173, 1035, 1015, 906, 829, 727, 647, 567; 1H NMR (400 MHz, CDCl3): δ = 7.35-
6.85 (m, 13H), 4.38-4.34 (m, 1H), 3.82 (s, 3H), 3.79 (s, 3H), 3.51 (bs, 3H), 2.51-2.46 (m, 1H), 2.39-2.28 
(m, 1H), 2.04 (s, 3H), 1.99-1.90 (m, 2H) ppm; 13C NMR (100 MHz, CDCl3): δ = 157.7, 142.2, 138.3, 
137.6, 137.5, 129.2, 126.7, 126.6, 125.9, 122.0, 121.3, 120.8, 120.7, 119.7, 118.7, 118.7, 113.5, 
111.6, 109.2, 108.6, 55.1, 39.9, 36.2, 32.6, 31.3, 30.9, 30.7, 27.2 ppm; MS (ESI): m/z [M+Na]+: 457.2. 
 
4-(1H-Indol-3-yl)-1-(4-methoxyphenyl)-4-methyl-2,3,4,9-tetrahydro-1H-carbazole (3c) 
Obtained as 1:1 diastereomeric mixture. Characterization of a 1: 0.81 diastereomeric ratio. IR (neat, 
ν/cm-1): 3408, 3054, 2933, 2846, 1611, 1509, 1455, 1304, 1240, 1175, 1101, 1031, 1013, 906, 830, 
728; 1H NMR (400 MHz, CDCl3): δ = 7.88 (d, J = 8.0 Hz, 1H, major isomer), 7.85 (s, 1H, minor isomer), 
7.78 (s, 1H, major isomer), 7.52 (d, J = 8.0 Hz, 1H, major isomer), 7.49 (d, J = 8.6 Hz, 2H, minor 
isomer), 7.40-6.81 (m, 9H major isomer and 12H minor isomer), 6.60 (d, J = 2.3 Hz, 1H, major 
isomer), 4.25-4.22 (m, 1H, minor isomer), 4.10 (dd, J = 10.5, 5.7 Hz, 1H, major isomer), 3.84 (s, 3H, 
minor isomer), 3.80 (s, 3H, major isomer), 2.73-2.69 (m, 1H, major isomer), 2.53-2.48 (m, 1H, minor 
isomer), 2.22-2.15 (m, 1H, major isomer), 2.12 (s, 3H, major isomer), 2.04 (s, 3H, minor isomer), 
2.02-1.97 (m, 1H major isomer and 3H minor isomer), 1.80-1.71 (m, 1H, major isomer) ppm; 13C NMR 
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(100 MHz, CDCl3): δ = 158.5 (2x), 137.4, 137.2, 136.6, 136.2, 136.1, 136.0, 135.9, 135.4, 129.3, 129.2, 
127.3, 126.9, 126.8, 125.930, 125.4, 125.0, 124.3, 124.2, 121.9, 121.3, 121.3, 121.0, 120.9, 120.9, 
120.8, 120.3, 118.9, 118.8, 118.7, 118.7, 118.5, 114.1, 114.0, 111.4, 111.1, 110.6, 110.5, 55.3, 55.2, 
41.7, 40.7, 38.6, 37.6, 36.8, 35.6, 30.9, 30.7, 28.8, 27.7 (one carbon missing due to overlapping) ppm; 
HRMS (ESI): m/z: calcd for C28H26N2NaO+: 429.1937, found: 429.1935. 
 
1-(1H-Indol-3-yl)-4-(4-methoxyphenyl)-1-methyl-2,3,4,9-tetrahydro-1H-carbazole (3’c), isomer 1 
IR (neat, ν/cm-1): 3400, 3051, 2926, 2854, 1614, 1508, 1457, 1332, 1306, 1240, 1175, 1103, 1031, 
1012, 831, 735; 1H NMR (500 MHz, CDCl3): δ = 7.84 (s, 1H), 7.78 (s, 1H), 7.47 (d, J = 8.1 Hz, 1H), 7.27 
(d, J = 8.1 Hz, 1H), 7.18-7.16 (m, 1H), 7.13 (d, J = 8.5 Hz, 2H), 7.09 (t, J = 7.6 Hz, 1H), 7.01 (t, J = 7.3 Hz, 
1H), 6.95 (t, J = 7.5 Hz, 1H), 6.88-6.82 (m, 2H), 6.75-7.72 (m, 3H), 4.15 (t, J = 6.7 Hz, 1H), 3.70 (s, 3H), 
2.52-2.47 (m, 1H), 2.16-2.11 (m, 1H), 1.88-1.83 (m, 1H), 1.85 (s, 3H), 1.78-1.72 (m, 1H) ppm; 13C NMR 
(125 MHz, CDCl3): δ = 157.8, 141.4, 138.3, 137.1, 135.9, 129.1, 127.3, 125.2, 123.6, 122.8, 121.8, 
121.2, 120.7, 119.9, 119.3, 119.0, 113.6, 112.0, 111.4, 110.6, 55.2, 39.3, 36.9, 36.2, 31.4, 27.7 ppm; 
HRMS (ESI): m/z: calcd for C28H26N2NaO+: 429.1937, found: 429.1936. 
 
1-(1H-Indol-3-yl)-4-(4-methoxyphenyl)-1-methyl-2,3,4,9-tetrahydro-1H-carbazole (3’c), isomer 2 
IR (neat, ν/cm-1): 3405, 3051, 2926, 2854, 1614, 1508, 1455, 1327, 1265, 1240, 1175, 1103, 1030, 
1011, 835, 739; 1H NMR (400 MHz, CDCl3): δ = 7.96 (s, 1H), 7.64 (s, 1H), 7.35 (d, J = 8.2 Hz, 1H), 7.23 
(d, J = 8.6 Hz, 2H), 7.16-7.08 (m, 3H), 7.04-7.01 (m, 2H), 6.92-6.84 (m, 5H), 4.33 (dd, J = 8.3, 5.7 Hz, 
1H), 3.83 (s, 3H), 2.57-2.50 (m, 1H), 2.27-2.19 (m, 1H), 2.06-1.90 (m, 2H), 1.95 (s, 3H)  ppm; 13C NMR 
(125 MHz, CDCl3): δ = 157.9, 141.9, 138.5, 136.9, 135.9, 129.0, 127.2, 125.5, 123.4, 121.9, 121.8, 
120.9, 120.5, 119.9, 119.6, 118.8, 113.7, 111.7, 111.2, 110.6, 55.2, 39.9, 37.6, 35.6, 32.3, 27.6  ppm; 
HRMS (ESI): m/z: calcd for C28H26N2NaO+: 429.1937, found: 429.1936. 
 
9-(4-Methoxybenzyl)-4-(1-(4-methoxybenzyl)-1H-indol-3-yl)-1-(4-methoxyphenyl)-4-methyl-2,3,4,9-tetrahydro-1H-carbazole 
(3d) 
Obtained as 2:1 diastereomeric mixture. Characterization of a 1:0.63 diastereomeric ratio. IR (neat, 
ν/cm-1): 3048, 3002, 2931, 2834, 1610, 1509, 1462, 1353, 1326, 1243, 1173, 1033, 828, 731, 535; 1H 
NMR (400 MHz, CDCl3): δ = 7.72 (d, J = 8.2 Hz, 1H, minor isomer), 7.59 (d, J = 7.9 Hz, 1H, major 
isomer), 7.47-7.43 (m, 1H major and minor isomer), 7.22-6.52 (m, 16H major isomer and 13H minor 
isomer), 6.52 (s, 1H, major isomer), 5.19-5.01 (m, 6H, major and minor isomer), 4.68-4.63 (m, 2H, 
major and minor isomer), 3.99-3.94 (m, 1H, major and minor isomer), 3.76 (s, 3H, major isomer), 
3.72 (s, 3H, minor isomer), 3.71 (s, 3H, major isomer), 3.71 (s, 3H, major isomer), 3.70 (s, 3H, minor 
isomer), 3.70 (s, 3H, minor isomer), 2.41-2.29 (m, 1H, major and minor isomer), 2.23-2.14 (m, 1H, 
major isomer), 2.09 (s, 3H, major isomer), 2.06-2.4 (m, 1H, minor isomer), 2.00 (s, 3H, minor isomer), 
1.97-1.94 (m, 1H, minor isomer), 1.92-1.88 (m, 1H, major isomer), 1.77-1.64 (m, 2H, major isomer) 
ppm; 13C NMR (100 MHz, CD2Cl2) (major and minor isomer): δ = 158.9, 158.8, 158.7, 158.6, 158.2, 
158.1, 157.9, 137.5, 137.5, 137.5, 137.4, 136.5, 136.5, 136.2, 136.1, 130.5, 130.3, 130.1, 129.9, 
129.1, 128.8, 127.8, 127.7, 127.4, 127.2, 127.1, 126.8, 126.5, 126.4, 126.4, 126.3, 124.0, 123.2, 
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121.4, 121.3, 121.2, 121.1, 121.0, 120.9, 120.8, 120.7, 119.5, 119.3, 118.6, 118.5, 118.4, 114.1, 
114.1, 114.0, 113.9, 113.9, 113.8, 109.9, 109.8, 109.3, 109.2, 55.2, 55.2, 55.1, 49.2, 49.1, 45.9, 45.8, 
38.9, 38.1, 36.7, 36.4, 34.6, 31.3, 30.4, 29.7, 29.1, 28.1 ppm; HRMS (ESI): m/z: calcd for 
C44H42N2NaO3+: 669.3087, found: 669.3087. 
 
9-Cinnamyl-4-(1-cinnamyl-1H-indol-3-yl)-1-(4-methoxyphenyl)-4-methyl-2,3,4,9-tetrahydro-1H-carbazole (3e) 
Obtained as 2:1 diastereomeric mixture. Characterization of a 1:0.57 diastereomeric ratio. IR (neat, 
ν/cm-1): 3056, 3020, 2952, 2932, 2854, 1609, 1509, 1463, 1355, 1327, 1246, 1176, 1032, 965, 908, 
833, 733, 692; 1H NMR (400 MHz, CDCl3): δ = 7.78 (d, J = 8.0 Hz, 1H, minor isomer), 7.74 (d, J = 8.0 
Hz, 1H, major isomer), 7.55 (d, J = 7.9 Hz, 1H, major isomer), 7.50 (d, J= 7.9 Hz, 1H, minor isomer), 
7.36-6.92 (m, 22H major isomer and 18H minor isomer), 6.84-6.82 (m, 2H major isomer and 1H 
minor isomer), 6.65 (d, J = 8.6 Hz, 2H, minor isomer), 6.51 (s, 1H, major isomer), 6.35-5.87 (m, 4H, 
major and minor isomer), 4.86-4.63 (m, 3H, major and minor isomer), 4.50-4.39 (m, 1H, major and 
minor isomer), 4.24 (dd, J = 5.4, 2.5 Hz, 1H, major isomer), 4.21 (t, J = 6.1 Hz, 1H, minor isomer), 3.74 
(s, 3H, major isomer), 3.56 (s, 3H, minor isomer), 2.50-2.38 (m, 1H, major and minor isomer), 2.34-
2.27 (m, 1H, minor isomer), 2.20-2.12 (m, 1H, major isomer), 2.15 (s, 3H, major isomer), 2.06 (s, 3H, 
minor isomer), 2.02-1.94 (m, 1H, major and minor isomer), 1.87-1.80 (m, 1H, minor isomer), 1.77-
1.72 (m, 1H, major isomer) ppm; 13C NMR (100 MHz, CDCl3) (major and minor isomer): 158.2, 158.1, 
137.5, 137.4, 137.1, 137.0, 136.7, 136.5, 136.5, 136.4, 136.4, 136.4, 136.2, 136.0, 131.5, 131.3, 
131.1, 131.0, 129.4, 129.0, 128.5, 128.5, 128.4, 128.4, 127.9, 127.6, 127.6, 127.5, 127.5, 127.2, 
127.2, 126.6, 126.4, 126.4, 126.4, 126.3, 126.3, 126.3, 125.5, 125.4, 125.3, 125.3, 123.9, 122.9, 
121.4, 121.3, 121.2, 121.2, 121.0, 120.9, 120.7, 120.7, 119.2, 118.9, 118.6, 118.5, 118.4, 118.3, 
113.9, 113.8, 109.8, 109.6, 109.3, 109.2, 55.1, 55.0, 48.0, 47.8, 45.5, 45.0, 39.1, 37.9, 36.7, 36.5, 
34.2, 30.1, 29.4, 28.1, 22.3, 14.0 ppm; HRMS (ESI): m/z: calcd for C46H42N2NaO+: 661.3189, found: 
661.3187. 
 
1-(4-Methoxyphenyl)-4-methyl-9-pentyl-4-(1-pentyl-1H-indol-3-yl)-2,3,4,9-tetrahydro-1H-carbazole (3f) 
Obtained as 2:1 diastereomeric mixture. Characterization of a 1:1 diastereomeric ratio. IR (neat, 
ν/cm-1): 3046, 2955, 2929, 2870, 1609, 1509, 1464, 1363, 1327, 1244, 1174, 1104, 1035, 906, 831, 
728, 648; 1H NMR (400 MHz, CDCl3): δ = 7.76 (d, J = 8.0 Hz, 1H), 7.72 (d, J = 8.0 Hz, 1H), 7.51 (d, J = 
7.9 Hz, 1H), 7.45 (d, J = 7.9 Hz, 1H), 7.31-7.27 (m, 4H), 7.18-7.11 (m, 4H), 7.07-7.00 (m, 6H), 6.98-6.92 
(m, 2H), 6.83 (d, J = 8.7 Hz, 2H), 6.78-6.74 (m, 3H), 6.37 (s, 1H), 4.20-4.16 (m, 2H), 4.00 (t, J = 7.2 Hz, 
2H), 3.94-3.89 (m, 2H), 3.88-3.82 (m, 2H), 3.80 (s, 3H), 3.75 (s, 3H), 3.73-3.60 (m, 2H), 2.42-2.24 (m, 
3H), 2.11 (s, 3H), 2.09-2.02 (m, 1H), 2.00 (s, 3H), 1.92 (dt, J = 13.0, 2.1 Hz, 1H), 1.80-1.63 (m, 7H), 
1.42-1.06 (m, 20H), 0.87-0.81 (m, 12H) ppm; 13C NMR (100 MHz, CDCl3): δ = 158.2, 158.1, 137.2, 
137.1, 136.9, 136.8, 136.7, 136.4, 136.3, 135.9, 130.9, 129.2, 128.9, 127.9, 127.2, 126.5, 126.4, 
126.2, 126.1, 123.2, 122.6, 122.2, 121.4, 121.3, 121.1, 120.6, 120.5, 120.3, 118.6, 118.4, 118.2, 
118.1, 117.9, 117.9, 113.8, 113.7, 109.5, 109.4, 109.1, 109.0, 55.2, 55.2, 47.7, 46.1, 45.9, 43.6, 43.2, 
39.2, 38.1, 36.6, 36.5, 34.0, 31.3, 31.3, 30.0, 29.9, 29.9, 29.7, 29.5, 29.4, 29.4, 29.2, 29.1, 29.1, 29.0, 
28.1, 22.4, 22.3, 22.291, 22.2, 13.9, 13.9  ppm; HRMS (ESI): m/z: calcd for C38H46N2NaO+: 569.3502, 
found: 569.3496. 
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6-Methoxy-4-(5-methoxy-1-methyl-1H-indol-3-yl)-1-(4-methoxyphenyl)-4,9-dimethyl-2,3,4,9-tetrahydro-1H-carbazole (3g) 
IR (neat, ν/cm-1): 2932, 2832, 1614, 1577, 1509, 1484, 1452, 1245, 1213, 1176, 1150, 1040, 910, 837, 
790, 727; 1H NMR (400 MHz, CDCl3): δ = 7.20-7.15 (m, 3H), 7.01-6.97 (m, 3H), 6.88-6.82 (m, 4H), 6.35 
(s, 3H), 4.18-4.17 (m, 1H), 3.81 (s, 3H), 3.80 (s, 3H), 3.74 (s, 3H), 3.57 (s, 3H), 3.36 (s, 3H), 2.36-2.29 
(m, 1H), 2.13-2.05 (m, 1H), 2.07 (s, 3H), 1.86 (dt, J = 13.0, 1.65 Hz, 1H), 1.73-1.69 (m, 1H) ppm; 13C 
NMR (100 MHz, CDCl3): δ = 158.1, 153.2, 152.9, 136.9, 136.1, 133.6, 132.9, 129.6, 129.1, 126.6, 
126.1, 121.4, 118.2, 113.7, 110.4, 110.2, 109.8, 109.1, 103.9, 103.9, 56.1, 56.1, 55.2, 37.9, 36.4, 33.8, 
32.6, 29.9, 29.4, 29.1 ppm; HRMS (ESI): m/z: calcd for C32H34rN2NaO3+: 517.2462, found: 517.2461. 
 
9-Benzyl-4-(1-benzyl-5-methoxy-1H-indol-3-yl)-6-methoxy-1-(4-methoxyphenyl)-4-methyl-2,3,4,9-tetrahydro-1H-carbazole 
(3h) 
Obtained as 2:1 diastereomeric mixture. Characterization of a 1:0.40 diastereomeric ratio. IR (neat, 
ν/cm-1): 3054, 3031, 2931, 2829, 1616, 1575, 1509, 1482, 1451, 1353, 1299, 1245, 1215, 1175, 1035, 
909, 834, 793, 732, 702; 1H NMR (400 MHz, CDCl3): δ = 7.25-6.18 (m, 20H, major and minor isomer), 
6.68 (d, J = 8.7 Hz, 2H, minor isomer), 6.57 (s, 1H, major isomer), 5.23 (d, J = 6.6 Hz, 1H, minor 
isomer), 5.16 (s, 2H, major isomer), 5.07 (d, J = 17.0 Hz, 1H, major and minor isomer), 4.77 (d, J = 
17.0 Hz, 1H, major isomer), 4.74 (d, J = 17.1 Hz, 1H, minor isomer), 4.02 (dd, J = 5.4, 2.9 Hz, 1H, major 
isomer), 3.98 (t, J = 5.7 Hz, 1H, minor isomer), 3.80 (s, 3H, major isomer), 3.78 (s, 3H, major isomer), 
3.77 (s, 3H, minor isomer), 3.74 (s, 3H, minor isomer), 3.68 (s, 3H, major isomer), 3.62 (s, 3H, minor 
isomer), 2.43-2.35 (m, 1H, major and minor isomer), 2.30-2.22 (m, 1H, minor isomer), 2.12 (s, 3H, 
major isomer), 2.10-2.04 (m, 1H, major isomer), 2.03 (s, 3H, minor isomer), 2.01-1.96 (m, 1H, minor 
isomer), 1.91 (dt, J =12.9, 1.9 Hz, 1H, major isomer), 1.82-1.77 (m, 1H, minor isomer), 1.73-1.68 (m, 
1H, major isomer) ppm; 13C NMR (100 MHz, CDCl3) (major and minor isomer): 158.2, 158.1, 153.3, 
153.2, 153.1, 138.4, 138.4, 138.2, 138.0, 137.2, 136.9, 136.6, 136.1, 133.0, 132.9, 132.7, 132.6, 
129.1, 128.9, 128.8, 128.6, 128.6, 128.5, 128.4, 128.1, 127.3, 127.3, 127.0, 126.9, 126.8, 126.7, 
126.6, 126.6, 126.4, 126.3, 125.9, 123.3, 122.3, 119.1, 118.8, 113.8, 113.8, 111.0, 110.7, 110.6, 
110.5, 110.4, 110.4, 109.9, 109.8, 104.2, 104.0, 103.5, 103.5, 56.0, 56.0, 55.8, 55.7, 55.2, 55.2, 49.9, 
49.8, 46.6, 46.5, 39.0, 38.1, 36.4, 36.3, 34.1, 31.2, 30.2, 29.7, 28.9, 27.7 ppm (two carbon are missing 
due to overlapping); HRMS (ESI): m/z: calcd for C44H42N2NaO3+: 669.3087, found: 669.3086. 
 
6-Bromo-4-(5-bromo-1-methyl-1H-indol-3-yl)-1-(4-methoxyphenyl)-4,9-dimethyl-2,3,4,9-tetrahydro-1H-carbazole (3i) 
Obtained as 2:1 diastereomeric mixture. IR (neat, ν/cm-1): 2931, 2855, 1609, 1509, 1469, 1420, 1370, 
1245, 1176, 1096, 1035, 986, 907, 788, 730; 1H NMR (400 MHz, CD2Cl2): δ = 7.72 (s, 1H, major 
isomer), 7.63 (s, 1H, minor isomer), 7.56 (s, 1H, major isomer), 7.30 (s, 1H, minor isomer), 7.25-7.15 
(m, 4H, major and minor isomer), 7.09 (d, J = 8.3 Hz, 2H, minor isomer), 6.97 (d, J = 8.4 Hz, 2H, major 
isomer), 6.91 (s, 1H, major isomer), 6.89 (s, 1H, minor isomer), 6.84 (d, J = 8.4 Hz, 2H, major isomer) 
6.39 (s, 1H, major isomer), 4.26-4.21 (m, 1H, major and minor isomer), 3.78 (s, 3H, major isomer), 
3.77 (s, 3H, minor isomer), 3.59 (s, 3H, major isomer), 3.37 (s, 3H, minor isomer), 3.35 (s, 3H, major 
isomer), 2.46-2.39 (m, 1H, minor isomer), 2.31-2.19 (m, 1H, major and minor isomer), 2.11-2.06 (m, 
1H, major and minor isomer), 2.03 (s, 3H, major isomer), 1.96-1.89 (m, 1H, major and minor isomer), 
1.86 (s, 3H, minor isomer), 1.76-1.71 (m, 1H, major and minor isomer) ppm; 13C NMR (100 MHz, 
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CD2Cl2) (major and minor isomer): δ = 158.9, 158.8, 138.5, 138.4, 137.3, 137.2, 136.8, 136.7, 136.4, 
136.2, 130.3, 129.6, 129.3, 129.1, 128.4, 128.2, 128.1, 124.2, 124.1, 123.8, 123.8, 123.7, 123.6, 
123.5, 123.4, 122.8, 122.4, 118.5, 114.7, 114.4, 112.2, 112.1, 112.1, 111.9, 111.5, 111.4, 110.9, 55.7, 
38.6, 38.4, 36.7, 36.5, 36.3, 34.9, 33.3, 33.2, 31.1, 30.4, 30.3, 30.1, 29.5, 27.9 ppm; HRMS (ESI): m/z: 
calcd for C30H28Br2N2NaO+: 613.0457, found: 613.0460. 
 
9-Benzyl-4-(1-benzyl-5-bromo-1H-indol-3-yl)-6-bromo-1-(4-methoxyphenyl)-4-methyl-2,3,4,9-tetrahydro-1H-carbazole (3j) 
Obtained as 2:1 diastereomeric mixture. IR (neat, ν/cm-1): 3062, 3028, 2930, 2857, 2835, 1606, 1508, 
1463, 1452, 1353, 1245, 1176, 1031, 988, 907, 831, 790, 696; 1H NMR (500 MHz, CDCl3): δ = 7.8 (s, 
1H, minor isomer), 7.68 (s, 1H, major isomer), 7.55 (s, 1H, major isomer), 7.48 (s, 1H, minor isomer), 
7.35-7.32 (m, 2H, major and minor isomer),  7.27-6.97 (m, 12H major isomer and 13H minor isomer), 
6.85-6.77 (m, 4H, major and minor), 6.66 (s, 1H, major isomer), 5.33-5.19 (m, 2H major and minor 
isomer), 5.12 (d, J = 17.1 Hz, 1H, minor isomer), 5.07 (d, J = 17.1 Hz, 1H, major isomer), 4.82 (d, J = 
17.1 Hz, 1H, minor isomer), 4.73 (d, J = 17.1 Hz, 1H, major isomer), 4.04-4.02 (m, 1H major and minor 
isomer), 3.82 (s, 3H, major isomer), 3.77 (s, 3H, minor isomer), 2.37-2.29 (m, 2H, major isomer), 
2.12-2.09 (m, 2H, minor isomer), 2.06 (s, 3H, major isomer), 1.95 (s, 3H, minor isomer), 1.92-1.81 (m, 
1H major isomer and 2H minor isomer), 1.78-1.76 (m, 1H, major isomer) ppm; 13C NMR (125 MHz, 
CD2Cl2) (major and minor isomer): δ = 158.2, 158.1, 137.7, 137.6, 137.5, 137.4, 137.2, 136.1, 136.0, 
136.0, 135.6, 135.5, 128.9, 128.9, 128.8, 128.7, 128.6, 128.5, 127.9, 127.8, 127.8, 127.5, 127.4, 
127.2, 127.1, 126.2, 126.1, 125.8, 125.7, 124.1, 124.0, 123.8, 123.7, 123.5, 123.3, 122.9, 122.8, 
122.6, 118.6, 118.5, 114.1, 113.9, 112.1, 112.0, 111.9, 111.4, 111.3, 110.9, 110.8, 55.2, 55.2, 49.9, 
49.9, 46.6, 46.5, 38.2, 38.0, 35.9, 35.8, 35.6, 34.9, 30.5, 28.8, 27.6 ppm; HRMS (ESI): m/z: calcd for 
C42H36Br2N2NaO+: 765.1087, found: 765.1088. 
 
4-(1,5-Dimethyl-1H-indol-3-yl)-1-(4-methoxyphenyl)-4,6,9-trimethyl-2,3,4,9-tetrahydro-1H-carbazole (3k) 
Obtained as 2:1 diastereomeric mixture. Characterization of a 1:0.63 diastereomeric ratio. IR (neat, 
ν/cm-1): 3032, 2929, 2866, 1609, 1508, 1486, 1461, 1371, 1245, 1175, 1092, 1034, 908, 833, 790, 
731; 1H NMR (400 MHz, CDCl3): δ = 7.61 (s, 1H, major isomer), 7.55 (s, 1H, minor isomer), 7.38 (s, 1H, 
major isomer), 7.06-6.96 (m, 4H major isomer and 5H minor isomer), 7.22-7.14 (m, 3H major isomer 
and 2H minor isomer), 6.83-6.78 (m, 2H major and minor isomer), 6.67 (s, 1H, minor isomer), 6.25 (s, 
1H, major isomer), 4.18-4.15 (m, 1H, major and minor isomer), 3.79 (s, 3H, major isomer), 3.77 (s, 
3H, minor isomer), 3.65 (s, 3H, minor isomer), 3.55 (s, 3H, major isomer), 3.37 (s, 3H, major isomer), 
3.30 (s, 3H, minor isomer), 2.48 (s, 3H, major isomer), 2.44 (s, 3H, minor isomer), 2.39 (s, 3H, major 
isomer), 2.35 (s, 3H, minor isomer), 2.31-2.21 (m, 1H, major and minor isomer), 2.11 (s, 3H, major 
isomer), 2.09-2.03 (m, 1H, major isomer), 1.99 (s, 3H, minor isomer), 1.96-1.92 (m, 1H, minor 
isomer), 1.89-1.77 (m, 1H, major and minor isomer), 1.70-1.66 (m, 1H, major isomer) ppm; 13C NMR 
(100 MHz, CD2Cl2) (major and minor isomer): δ = 158.1, 158.0, 137.0, 136.8, 136.5, 136.4, 136.3, 
136.2, 135.9, 135.8, 129.4, 129.2, 128.8, 128.2, 127.4, 127.3, 127.2, 127.1, 126.5, 126.4, 125.9, 
122.7, 122.4, 122.3, 122.0, 121.9, 121.6, 121.2, 121.0, 121.0, 120.8, 118.4, 118.2, 113.9, 113.7, 
110.0, 109.1, 108.9, 108.3, 108.2, 55.3, 55.2, 39.3, 39.3, 37.7, 36.9, 36.6, 36.6, 33.5, 32.6, 32.5, 31.4, 
30.1, 29.7, 29.5, 29.3, 28.2, 21.7, 21.6, 21.5 ppm; HRMS (ESI): m/z: calcd for C22H34N2NaO+: 485.2563, 
found: 485.2560. 
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9-Benzyl-4-(1-benzyl-5-methyl-1H-indol-3-yl)-1-(4-methoxyphenyl)-4,6-dimethyl-2,3,4,9-tetrahydro-1H-carbazole (3l), major 
diastereoisomer 
Obtained as 2:1 diastereomeric mixture. IR (neat, ν/cm-1): 3056, 3025, 2928, 2858, 1608, 1508, 1495, 
1481, 1453, 1372, 1354, 1300, 1246, 1177, 1033, 909, 834, 789, 732, 701; 1H NMR (500 MHz, 
CDCl3)(major diastereoisomer): δ = 7.52 (s, 1H), 7.34 (s, 1H), 7.23 (d, J = 7.5 Hz, 2H), 7.20 (d, J = 7.1 
Hz, 1H), 7.17-7.16 (m, 3H), 7.09 (t, J = 7.8 Hz, 2H), 7.0-6.97 (m, 3H), 6.95-6.90 (m, 2H), 6.86-6.84 (m, 
2H), 6.81 (d, J = 8.6 Hz, 2H), 6.52 (s, 1H), 5.20-5.13 (m, 2H), 5.08 (d, J = 17.0 Hz, 1H), 4.74 (d, J = 17.0 
Hz, 1H), 4.00 (dd, J = 5.4, 2.8 Hz, 1H), 3.80 (s, 3H), 2.43 (s, 3H), 2.41-2.34 (m, 1H), 2.34 (s, 3H), 2.13 (s, 
3H), 2.10-2.04 (m, 1H), 1.90 (dt, J = 13.0, 2.1 Hz, 1H), 1.69-1.65 (m, 1H) ppm; 13C NMR (125 MHz, 
CD2Cl2): 158.2, 138.6, 138.1, 136.2, 136.2, 136.0, 135.8, 129.2, 128.6, 128.6, 128.4, 127.7, 127.5, 
127.2, 126.9, 126.7, 126.5, 126.3, 125.9, 122.6, 122.5, 122.3, 121.1, 120.9, 118.8, 113.8, 109.6, 
109.0, 55.2, 49.7, 46.3, 37.9, 36.4, 34.2, 30.2, 29.2, 21.7, 21.5 ppm; HRMS (ESI): m/z: calcd for 
C44H42N2NaO+: 637.3189, found: 637.3192. 
 
9-Benzyl-4-(1-benzyl-5-methyl-1H-indol-3-yl)-1-(4-methoxyphenyl)-4,6-dimethyl-2,3,4,9-tetrahydro-1H-carbazole (3l), minor 
diastereoisomer 
Obtained as 2:1 diastereomeric mixture. IR (neat, ν/cm-1): 3056, 3025, 2928, 2858, 1608, 1508, 1495, 
1481, 1453, 1372, 1354, 1300, 1246, 1177, 1033, 909, 834, 789, 732, 701; 1H NMR (500 MHz, 
CDCl3)(major diastereoisomer): δ = 7.59 (s, 1H), 7.30 (s, 1H), 7.24-6.80 (m, 17H), 6.68 (d, J = 8.3 Hz, 
2H), 5.23 (dd, J = 30.4, 16.5 Hz, 2H), 5.09 (d, J = 17.0 Hz, 1H), 4.74 (d, J = 17.1 Hz, 1H), 3.97 (t, J = 5.8 
Hz, 1H), 3.74 (s, 3H), 2.45-2.40 (m, 1H), 2.42 (s, 3H), 2.32 (s, 3H), 2.28-2.19 (m, 1H), 2.03 (s, 3H), 2.00-
1.95 (m, 1H), 1.82-1.77 (m, 1H) ppm; 13C NMR (125 MHz, CDCl3): 158.0, 138.5, 138.3, 136.6, 136.5, 
135.9, 135.9, 128.9, 128.6, 128.5, 127.7, 127.6, 127.4, 127.1, 126.8, 126.6, 126.5, 126.2, 125.9, 
123.4, 122.7, 122.2, 121.1, 121.1, 119.1, 113.8, 109.5, 108.9, 55.2, 49.6, 46.5, 38.8, 36.6, 36.4, 31.2, 
28.0, 21.5, 21.5 ppm (one carbon is missing due to overlapping); HRMS (ESI): m/z: calcd for 
C44H42N2NaO+: 637.3189, found: 637.3192. 
 
5-(5-Cyano-1-methyl-1H-indol-3-yl)-8-(4-methoxyphenyl)-5,9-dimethyl-6,7,8,9-tetrahydro-5H-carbazole-3-carbonitrile (3m), 
major diastereoisomer 
IR (neat, ν/cm-1): 2963, 2926, 2858, 2217, 1609, 1509, 1482, 1375, 1245, 1176, 1091, 1033, 907, 801, 
718; 1H NMR (400 MHz, CDCl3): δ = 7.71 (s, 1H), 7.62 (s, 1H), 7.40-7.36 (m, 2H), 7.33-7.30 (m, 2H), 
6.99 (d, J = 8.5 Hz, 2H), 6.87 (d, J = 8.5 Hz, 2H), 6.63 (s, 1H), 4.26 (t, J = 4.8 Hz, 1H), 3.81 (s, 3H), 3.72 
(s, 3H), 3.40 (s, 3H), 2.27-2.22 (m, 1H), 2.18-2.10 (m, 1H), 2.02 (s, 3H), 1.96-1.83 (m, 2H) ppm; 13C 
NMR (100 MHz, CDCl3): δ = 158.4, 139.4, 139.0, 135.2, 129.6, 128.8, 126.3, 125.6, 125.5, 124.1, 
123.9, 123.7, 121.1, 121.0, 118.9, 114.2, 110.3, 109.7, 101.5, 101.4, 55.3, 38.3, 35.8, 35.6, 32.9, 30.4, 
30.1, 29.1(two carbon missing due to overlapping) ppm; HRMS (ESI): m/z: calcd for C32H28N4NaO+: 
507.2155, found: 507.22151. 
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5-(5-Cyano-1-methyl-1H-indol-3-yl)-8-(4-methoxyphenyl)-5,9-dimethyl-6,7,8,9-tetrahydro-5H-carbazole-3-carbonitrile 
(3m),minor diastereoisomer 
IR (neat, ν/cm-1): 2963, 2926, 2858, 2217, 1609, 1509, 1482, 1375, 1245, 1176, 1091, 1033, 907, 801, 
718; 1H NMR (400 MHz, CDCl3): δ = 7.73 (s, 1H), 7.39 (s, 1H), 7.35-7.29 (m, 4H), 7.09-7.07 (m, 3H), 
6.96 (d, J = 8.6 Hz, 2H), 4.29 (dd, J = 5.7. 3.1 Hz, 1H), 3.83 (s, 3H), 3.81 (s, 3H), 3.49 (s, 3H), 2.56-2.48 
(m, 1H), 2.32-2.23 (m, 1H), 2.11-2.07 (m, 1H), 1.85 (s, 3H), 1.72-1.68 (m, 1H) ppm; 13C NMR (100 
MHz, CDCl3): δ = 158.5, 139.3, 138.9, 138.6, 134.6, 128.7, 128.6, 126.5, 125.6, 125.1, 124.3, 124.1, 
124.0, 121.2, 120.9, 118.8, 114.4, 110.3, 109.7, 101.4, 101.3, 55.3, 37.3, 37.3, 35.5, 33.1, 30.1, 29.9, 
27.4 ppm; HRMS (ESI): m/z: calcd for C32H28N4NaO+: 507.2155, found: 507.22151. 
 
(E)-9-Benzyl-4-(1-benzyl-1H-indol-3-yl)-4-methyl-1-(1-phenylprop-1-en-2-yl)-2,3,4,9-tetrahydro-1H-carbazole (3n) 
Obtained as 1:1 diastereomeric mixture. Characterization of a 1:0.5 diastereomeric ratio. IR (neat, 
ν/cm-1): 3084, 3047, 3027, 2929, 2857, 1604, 1463, 1453, 1354, 1327, 1178, 1074, 1027, 908, 729, 
697; 1H NMR (400 MHz, CDCl3): δ = 7.79 (d, J = 8.0 Hz, 1H, major isomer), 7.63 (d, J = 7.5 Hz, 1H, 
minor isomer), 7.47-7.38 (m, 1H, major and minor isomer), 7.33-6.91 (m, 23H, major and minor 
isomer), 6.84 (s, 1H, major isomer), 6.61 (s, 1H, minor isomer), 6.24 (s, 1H, major isomer), 6.08 (s, 
1H, minor isomer), 5.41-5.16 (m, 4H, major and minor isomer), 3.55 (t, J = 5.6 Hz, 1H, major isomer), 
3.49-3.47 (m, 1H, minor isomer), 2.61-2.55 (m, 1H, major isomer), 2.48-2.42 (m, 1H, minor isomer), 
2.09 (s, 3H, minor isomer), 2.06-2.00 (m, 1H, major isomer), 2.02 (s, 3H, major isomer), 1.95 (s, 3H, 
minor isomer), 1.92-1.86 (m, 1H, minor isomer), 1.77 (s, 3H, major isomer) ppm; 13C NMR (125 MHz, 
CDCl3): δ = 139.8, 139.5, 138.5, 138.4, 138.1, 138.0, 137.9, 137.9, 137.6, 137.5, 137.4, 135.8, 135.7, 
128.9, 128.8, 128.7, 128.6, 128.6, 128.5, 128.3, 128.2, 128.0, 128.0, 127.9, 127.7, 127.4, 127.3, 
127.2, 127.1, 127.0, 126.4, 126.2, 126.1, 126.0, 126.0, 125.8, 125.6, 123.9, 121.4, 121.2, 121.1, 
121.1, 120.8, 120.8, 119.7, 119.5, 118.6, 118.4, 109.9, 109.8, 109.3, 109.3, 49.7, 46.6, 43.4, 42.6, 
36.6, 36.5, 36.3, 35.2, 29.7, 28.9, 28.2, 28.1, 26.1, 25.4, 17.6, 16.6 ppm (eight carbon are missing due 
to overlapping);  HRMS (ESI): m/z: calcd for C44H40N2Na+: 619.3083, found: 619.3080. 
 
(E)-5-(5-Cyano-1-methyl-1H-indol-3-yl)-5,9-dimethyl-8-(1-phenylprop-1-en-2-yl)-6,7,8,9-tetrahydro-5H-carbazole-3-
carbonitrile (3o), major diastereoisomer 
IR (neat, ν/cm-1): 2932, 2858, 2216, 1609, 1482, 1446, 1375 1228, 1139, 1087, 909, 802, 730; 1H NMR 
(400 MHz, CDCl3): δ = 7.70 (s, 1H), 7.59 (s, 1H), 7.40-7.31 (m, 6H), 7.23-7.22 (m, 3H), 6.63 (s, 1H), 
6.01 (s, 1H), 3.75-3.69 (m, 1H), 3.72 (s, 6H), 2.33-2.28 (m, 1H), 2.09-1.94 (m, 3H), 2.01 (s, 3H), 1.99 (s, 
3H) ppm; 13C NMR (125 MHz, CDCl3): δ = 139.3, 139.0, 138.7, 138.6, 137.6, 129.6, 128.7, 128.3, 
128.2, 126.5, 126.3, 125.6, 124.1, 123.9, 123.6, 121.1, 121.0, 119.0, 110.3, 109.6, 101.5, 101.4, 42.5, 
35.9, 35.8, 32.9, 29.9, 29.0, 25.2, 17.4 (two carbon missing due to overlapping) ppm; HRMS (ESI): 
m/z: calcd for C34H30N4Na+: 517.2363, found: 517.2362. 
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(E)-5-(5-Cyano-1-methyl-1H-indol-3-yl)-5,9-dimethyl-8-(1-phenylprop-1-en-2-yl)-6,7,8,9-tetrahydro-5H-carbazole-3-
carbonitrile (3o), minor diastereoisomer 
IR (neat, ν/cm-1): 2933, 2854, 2217, 1728, 1610, 1483, 1447, 1375, 1289, 1234, 1148, 1095, 910, 802, 
730, 699; 1H NMR (400 MHz, CDCl3): δ = 7.72 (s, 1H), 7.44 (s, 1H), 7.38-7.30 (m, 6H), 7.24-7.18 (m, 
3H), 6.90 (s, 1H), 6.19 (s, 1H), 3.78 (s, 3H), 3.71 (s, 3H), 3.71-3.68 (m, 1H), 2.43-2.36 (m, 1H), 2.29-
2.20 (m, 1H), 2.02-1.95 (m, 1H), 2.00 (s, 3H), 1.87 (s, 3H), 1.85-1.83 (m, 1H) ppm; 13C NMR (125 MHz, 
CDCl3): δ = 139.2, 138.9, 138.8, 138.4, 137.3, 128.9, 128.8, 128.2, 126.6, 126.1, 125.5, 125.4, 125.3, 
124.3, 124.1, 124.0, 121.2, 120.8, 119.1, 110.3, 109.7, 101.4, 101.3, 42.4, 36.5, 35.7, 33.0, 29.9, 27.7, 
25.4, 17.4 ppm; HRMS (ESI): m/z: calcd for C34H30N4Na+: 517.2363, found: 517.2362. 
 
(E)-6-Bromo-4-(5-bromo-1-methyl-1H-indol-3-yl)-4,9-dimethyl-1-(1-phenylprop-1-en-2-yl)-2,3,4,9-tetrahydro-1H-carbazole 
(3p),  isomer1 
IR (neat, ν/cm-1): 3020, 2937, 2856, 1737, 1472, 1362, 1281, 1229, 1147, 1095, 1049, 904, 794, 742; 
1H NMR (400 MHz, CDCl3): δ = 7.76 (s, 1H), 7.44 (s, 1H), 7.31-7.27 (m, 2H), 7.24-7.12 (m, 7H), 6.62 (s, 
1H), 6.24 (s, 1H), 3.69 (t, J = 5.9 Hz, 1H), 3.66 (s, 3H), 3.65 (s, 3H), 2.47-2.41 (m, 1H), 2.13-2.06 (m, 
1H), 1.93-1.84 (m, 2H), 1.90 (s, 3H), 1.87 (s, 3H) ppm; 13C NMR (100 MHz, CD3Cl): δ = 139.7, 137.8, 
137.4, 136.6, 136.2, 128.9, 128.8, 128.0, 127.8, 127.6, 127.4, 126.3, 123.9, 123.5, 123.4, 122.9, 
122.6, 118.3, 111.8, 111.7, 110.8, 110.1, 43.5, 36.8, 36.2, 32.8, 29.9, 28.0, 26.1, 16.7 ppm; HRMS 
(ESI): m/z: calcd for C32H30Br2N2NaO+: 623.0668, found: 623.0662. 
 
(E)-6-Bromo-4-(5-bromo-1-methyl-1H-indol-3-yl)-4,9-dimethyl-1-(1-phenylprop-1-en-2-yl)-2,3,4,9-tetrahydro-1H-carbazole 
(3p), isomer2 
IR (neat, ν/cm-1): 3020, 2937, 2856, 1737, 1472, 1362, 1281, 1229, 1147, 1095, 1049, 904, 794, 742; 
1H NMR (400 MHz, CDCl3): δ = 7.82 (s, 1H), 7.58 (s, 1H), 7.33-7.27 (m, 3H), 7.25-7.22 (m, 6H), 6.28 (s, 
1H), 5.84 (s, 1H), 3.61 (s, 3H), 3.58 (s, 3H), 3.58-3.55 (m, 1H), 2.35-2.31 (m, 1H), 2.08-2.04 (m, 1H), 
2.03 (s, 3H), 2.01 (s, 3H), 1.83-1.80 (m, 2H) ppm; 13C NMR (100 MHz, CD3Cl): δ = 138.8, 137.9, 137.5, 
136.7, 136.2, 129.8, 128.8, 128.2, 128.1, 127.7, 127.4, 126.3, 123.7, 123.4, 123.3, 123.2, 121.7, 
118.1, 111.9, 111.8, 110.9, 110.2, 41.9, 36.3, 34.4, 32.7, 29.4, 29.2, 24.4, 18.0  ppm; HRMS (ESI): m/z: 
calcd for C32H30Br2N2NaO+: 623.0668, found: 623.0662. 
 
9-Benzyl-4-(1-benzyl-1H-indol-3-yl)-4-methyl-1-(2-methylprop-1-enyl)-2,3,4,9-tetrahydro-1H-carbazole (3q) 
Obtained as 1:1 diastereomeric mixture. Characterization of a 1:1 diastereomeric ratio. IR (neat, 
ν/cm-1): 3060, 3025, 2962, 2928, 2857, 1605, 1463, 1452, 1369, 1326, 1178, 1027, 907, 729, 695; 1H 
NMR (400 MHz, CDCl3): δ = 7.60 (d, J = 8.0 Hz, 1H), 7.49 (d, J = 8.0 Hz, 1H), 7.40 (d, J = 7.8 Hz, 1H), 
7.31-7.27 (m, 3H), 7.25-7.16 (m, 13H), 7.13-6.96 (m, 11H), 6.94-6.87 (m, 6H), 6.84-6.80 (m, 1H), 6.63 
(s, 1H), 5.36-5.15 (m, 10H), 3.72-3.67 (m, 1H), 3.64-3.59 (m, 1H), 2.58 (ddd, J= 13.4, 11.1, 2.6 Hz, 1H), 
2.48 (ddd, J = 13.0, 7.1, 2.4 Hz, 1H), 2.15-2.09 (m, 1H), 2.07 (s, 3H), 2.05-1.96 (m, 1H), 1.95 (s, 3H), 
1.92-1.77 (m, 3H), 1.68-1.60 (m, 1H), 1.66 (d, J = 1.1 Hz, 3H), 1.63 (d, J = 1.1 Hz, 3H), 1.62 (d, J = 1.0 
Hz, 3H), 1.51 (d, J = 1.1 Hz, 3H) ppm; 13C NMR (125 MHz, CDCl3): δ = 138.7, 138.6, 138.1, 138.0, 
137.9, 137.6, 137.5, 137.4, 137.3, 137.2, 131.6, 131.4, 128.7, 128.7, 128.6, 128.5, 128.5, 128.4, 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
127.6, 127.3, 127.3, 127.2, 126.8, 126.7, 126.6, 126.6, 126.5, 126.4, 126.3, 125.8, 125.7, 124.5, 
123.6, 121.2, 121.1, 121.0, 121.0, 120.8, 120.5, 120.5, 120.4, 120.4, 118.5, 118.4, 118.3, 118.3, 
117.4, 117.3, 109,8, 109.7, 109.1, 109.0, 49.7, 49.6, 46.3, 46.2, 36.8, 36.2, 36.1, 35.9, 32.4, 32.3, 
28.6, 28.2, 28.1, 27.5, 25.6, 25.5, 17.8,17.7 ppm; HRMS (ESI): m/z: calcd for C39H38N2Na+: 557.2927, 
found: 557.2924. 
 
6-Bromo-4-(5-bromo-1-methyl-1H-indol-3-yl)-4,9-dimethyl-1-(2-methylprop-1-enyl)-2,3,4,9-tetrahydro-1H-carbazole (3r) 
Obtained as 1:1 diastereomeric mixture. Characterization of a 1:0.45 diastereomeric ratio. IR (neat, 
ν/cm-1): 2962, 2921, 2852, 1471, 1420, 1370, 1275, 1229, 1141, 1089, 1049, 985, 906, 786, 729, 637, 
585; 1H NMR (400 MHz, CDCl3): δ = 7.80 (d, J = 1.7 Hz, 1H, major isomer), 7.59 (d, J = 0.8 Hz, 1H, 
minor isomer), 7.52 (d, J = 1.7 Hz, 1H, major isomer), 7.32 (d, J = 1.4 Hz, 1H, minor isomer), 7.27 (d, J 
= 1.8 Hz, 1H, minor isomer), 7.25 (d, J = 1.8 Hz, 1H, minor isomer), 7.22 (d, J = 1.8 Hz, 1H, minor 
isomer), 7.20 (d, J = 1.8 Hz, 1H, major isomer), 7.16 (s, 1H, major isomer), 7.14-7.11 (m, 2H major 
isomer and 1H minor isomer), 6.69 (s, 1H, minor isomer), 6.26 (s, 1H, major isomer), 5.37-5.34 (m, 
1H, major and minor isomer), 3.81-3.75 (m, 1H, minor isomer), 3.73-3.69 (m, 1H, major isomer), 3.69 
(s, 3H, minor isomer), 3.60 (s, 3H, minor isomer), 3.58 (s, 3H, major isomer), 3.57 (s, 3H, major 
isomer), 2.48-2.42 (m, 1H, minor isomer), 2.35 (ddd, J = 13.1, 5.4, 2.3 Hz, 1H, major isomer), 2.10-
2.04 (m, 1H, minor isomer), 2.02-1.95 (m, 1H, major isomer), 1.98 (s, 3H, major isomer), 1.85 (s, 3H, 
minor isomer), 1.83 (d, J = 1.1 Hz, 3H, minor isomer), 1.82-1.81 (m, 1H, major isomer), 1.79 (d, J = 1.1 
Hz, 3H major isomer), 1.77 (bs, 1H, major and minor isomer), 1.74-1.73 (m, 1H, minor isomer), 1.63-
1.56 (m, 1H, major and minor isomer) ppm; 13C NMR (100 MHz, CDCl3) (major and minor isomer): δ = 
139.7, 139.2, 136.7, 136.6, 136.1, 135.9, 132.0, 131.9, 129.7, 128.4, 128.4, 128.4, 128.3, 127.9, 
127.7, 127.6, 127.4, 126.7, 126.6, 123.7, 123.7, 123.4, 123.3, 123.0, 122.9, 122.5, 122.0, 116.0, 
115.9, 111.8, 111.6, 110.8, 110.7, 110.0, 36.9, 36.3, 35.7, 35.4, 32.8, 32.7, 32.6, 31.9, 29.7, 29.7, 
29.4, 29.0, 27.8, 27.7, 25.8, 25.8, 17.9, 17.9 ppm (two carbon are missing due to overlapping); HRMS 
(ESI): m/z: calcd for C27H28Br2N2Na+: 561.0511, found: 561.0506. 
 
9-Benzyl-4-(1-benzyl-1H-indol-3-yl)-1-(4-methoxyphenyl)-1,4-dimethyl-2,3,4,9-tetrahydro-1H-carbazole (3s) 
Obtained as 1:1 diastereomeric mixture. Characterization of a 1:0.70 diastereomeric ratio. IR (neat, 
ν/cm-1): 3056, 3025, 2963, 2928, 2854, 1606, 1509, 1463, 1350, 1327, 1299, 1245, 1181, 1074, 1029, 
908, 828, 730, 696; 1H NMR (400 MHz, CDCl3): δ = 7.89 (d, J = 7.8 Hz, 1H, minor isomer), 7.62 (d, J = 
7.5 Hz, 1H, minor isomer), 7.49 (d, J = 7.5 Hz, 1H, major isomer), 7.35-6.83 (m, 21H, major isomer 
and 17H minor isomer), 6.78 (d, J = 6.7 Hz, 2H, minor isomer), 6.70 (s, 1H, major isomer), 6.64 (d, J = 
8.3 Hz, 2H, minor isomer), 5.38-4.79 (m, 4H, major and minor isomer), 3.82 (s, 3H, major isomer), 
3.75 (s, 3H, minor isomer), 2.65-2.53 (m, 1H, major and minor isomer), 2.19 (s, 3H, minor isomer), 
2.18-2.13 (m, 1H, minor isomer), 2.06 (s, 3H, major isomer), 2.06-1.99 (m, 1H, major isomer), 1.97-
1.89 (m, 1H, major and minor isomer), 1.84-1.79 (m, 1H, major isomer), 1.72-1.68 (m, 1H, minor 
isomer), 1.67 (s, 3H, major isomer), 1.66 (s, 3H, minor isomer) ppm; 13C NMR (100 MHz, CDCl3) 
(major and minor isomer): 157.9, 157.7, 141.3, 141.1, 140.7, 140.1, 138.4, 138.3, 138.1, 138.0, 137.7, 
137.7, 137.6, 137.5, 128.6, 128.6, 128.4, 128.4, 127.6, 127.6, 127.5, 127.3, 127.3, 127.2, 127.2, 
127.1, 126.7, 126.6, 126.5, 126.4, 126.4, 126.2, 126.0, 125.8, 125.7, 124.3, 123.3, 121.4, 121.3, 
121.2, 121.1, 120.9, 120.8, 120.7, 118.9, 118.7, 118.6, 118.5, 118.4, 118.3, 113.7, 113.7, 109.9, 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
109.9, 109.8, 109.8, 55.2, 55.1, 49.7, 49.5, 47.6, 47.5, 42.0, 41.8, 40.1, 40.0, 37.4, 36.3, 36.0, 36.0, 
29.7, 29.3, 27.9, 25.7 ppm; HRMS (ESI): m/z: calcd for C43H40N2NaO+: 623.3033, found: 623.3032. 
 
1-(4-Methoxyphenyl)-1,4,9-trimethyl-4-(1-methyl-1H-indol-3-yl)-2,3,4,9-tetrahydro-1H-carbazole (3t) 
Obtained as 2:1 diastereomeric mixture. Characterization of a 1.5:1 diastereomeric ratio. IR (neat, 
ν/cm-1): 3051, 2963, 2930, 2837, 2358, 1744, 1608, 1509, 1468, 1371, 1326 1247, 1180, 1094, 1032, 
908, 828; 1H NMR (400 MHz, CDCl3): δ = 7.83 (d, J = 8.0 Hz, 1H, minor isomer), 7.55 (d, J = 8.0 Hz, 1H, 
minor isomer), 7.53-7.51 (m, 1H, major isomer), 7.37 (d, J = 7.9 Hz, major isomer), 7.28-7.25 (m, XH), 
7.21-7.05 (m, xH), 7.02-6.95 (m, 2H), 6.93-6.89 (m, 1H), 6.84 (d, J = 8.8 Hz, 2H, major isomer),  6.78 
(d, J = 8.8 Hz, 2H, minor isomer), 6.62 (s, 1H, major isomer), 6.52 (s, 1H, minor isomer), 3.81 (s, 3H, 
major isomer), 3.77 (s, 3H, minor isomer), 3.67 (s, 3H, major isomer), 3.62 (s, 3H, minor isomer), 3.36 
(s, 3H, major isomer), 3.24 (s, 3H, minor isomer), 2.59-2.54 (m, 1H, major isomer), 2.43-2.37 (m, 1H, 
major isomer), 2.14-2.07 (m, 1H, minor isomer), 2.09 (s, 3H, minor isomer), 2.03 (s, 3H, major 
isomer), 1.95-1.65 (m, 1H major isomer and 3H minor isomer), 1.86 (s, 3H, major isomer), 1.85 (s, 
3H, minor isomer) ppm; 13C NMR (100 MHz, CD2Cl2) (major and minor isomer): δ = 157.8, 157.6, 
141.4, 141.1, 140.5, 140.3, 138.1, 137.9, 137.8, 137.7, 128.8, 127.9, 127.6, 127.2, 127.2, 126.1, 
126.0, 126.0, 125.7, 122.9, 122.6, 121.4, 121.1, 121.0, 120.9, 120.8, 120.8, 120.5, 118.4, 118.4, 
118.3, 118.1, 118.1, 117.8, 113.7, 113.6, 109.3, 109.2, 108.5, 108.4, 55.2, 55.1, 41.6, 41.2, 39.9, 37.1, 
36.5, 36.1, 35.8, 32.5, 32.5, 31.6, 31.1, 29.4, 28.7, 28.7, 28.7, 25.1 ppm; HRMS (ESI): m/z: calcd for 
C31H32N2NaO+: 471.2406, found: 471.2409. 
 
6-Bromo-4-(5-bromo-1H-indol-3-yl)-1-(4-methoxyphenyl)-4-methyl-2,3,4,9-tetrahydro-1H-carbazole (3u) 
Obtained as 1:1 diastereomeric mixture. Characterization of a 1:0.76 ratio of diastereoisomers. IR 
(neat, ν/cm-1): 3420, 2962, 2933, 2852, 1605, 1507, 1455, 1310, 1235, 1170, 1025, 910, 800, 730; 1H 
NMR (400 MHz, CDCl3): δ = 7.96 (bs, 1H, minor isomer), 7.91 (s, 1H, major isomer), 7.88 (bs, 1H, 
major isomer), 7.56 (d, J = 1.3 Hz, 1H, major isomer), 7.54 (d, J = 7.5 Hz, 2H, minor isomer), 7.41 (s, 
1H, minor isomer), 7.28-7.04 (m, 7H major isomer, 9H minor isomer) , 6.98 (d, J = 2.0 Hz, 1H, minor 
isomer), 6.91 (d, J = 8.6 Hz, 2H, minor isomer), 6.86 (d, J = 8.6 Hz, 2H, major isomer), 6.62 (d, J = 2.3 
Hz, 1H, major isomer), 4.22 (dd, J = 8.0, 5.7 Hz, 1H, minor isomer), 4.08 (dd, J = 10.2, 5.5 Hz, 1H, 
major isomer), 3.83 (s, 3H, minor isomer), 3.79 (s, 3H, major isomer), 2.61-2.57 (m, 1H, major 
isomer), 2.46-2.39 (m, 1H, minor isomer), 2.20-2.13 (m, 1H, major isomer), 2.06-1.94 (m, 1H major 
isomer, 3H minor isomer), 2.02 (s, 3H, major isomer), 1.96 (s, 3H, minor isomer), 177-1.68 (m, 1H, 
major isomer) ppm; 13C NMR (100 MHz, CDCl3): δ = 158.7, 158.6, 138.0, 137.0, 136.0, 135.9, 135.4, 
135.3, 134.7, 134.7, 129.3, 129.1, 128.5, 128.3, 127.5, 127.1, 124.9, 124.4, 124.4, 124.4, 123.9, 
123.8, 123.8, 123.4, 123.1, 123.1, 123.0, 122.4, 118.0, 117.9, 114.3, 114.2, 112.8, 112.7, 112.3, 
112.3, 112.2, 112.1, 112.0, 55.3, 55.3, 41.5, 40.7, 38.5, 37.7, 36.4, 35.4, 30.7, 30.4, 28.7, 27.5 ppm 
(one carbon missing due to overlapping); HRMS (ESI): m/z: calcd for C28H24Br2N2NaO+: 585.0147, 
found: 585.0140. 
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6-Bromo-1-(5-bromo-1H-indol-3-yl)-4-(4-methoxyphenyl)-1-methyl-2,3,4,9-tetrahydro-1H-carbazole (3’u) 
Obtained as 1:1 diastereomeric mixture. Characterization of a 1:1 ratio of diastereoisomers. IR (neat, 
ν/cm-1): 3425, 2933, 2846, 1605, 1508, 1461, 1298, 1240, 1175, 1106, 1031, 905, 795, 727, 581; 1H 
NMR (400 MHz, CDCl3): δ = 8.03 (bs, 2H), 7.83 (s, 1H), 7.71 (s, 1H), 7.65 (s, 1H), 7.28 (s, 1H), 7.25-7.21 
(m, 4H), 7.19-7.10 (m, 8H), 7.05-7.01 (m, 2H), 6.91 (d, J = 2.3 Hz, 1H), 6.87-6.85 (m, 5H), 4.26 (t, J = 
6.5 Hz, 1H), 4.20 (t, J = 6.0 Hz, 1H), 3.82 (s, 3H), 3.79 (s, 3H), 2.50-2.45 (m, 1H), 2.43-2.36 (m, 1H), 
2.30-2.23 (m, 1H), 2.20-2.14 (m, 1H), 1.94-1.80 (m, 4H), 1.91 (s, 3H), 1.87 (s, 3H) ppm; 13C NMR (100 
MHz, CDCl3): δ = 158.0, 157.9, 142.6, 142.4, 137.6, 137.3, 135.7, 135.6, 134.6, 134.5, 129.2, 128.9, 
128.9, 127.0, 126.8, 125.0, 124.9, 124.2, 124.0, 123.8, 123.3, 123.1, 122.9, 122.8, 122.7, 122.3, 
122.2, 113.9, 113.8, 112.8, 112.8, 112.7, 112.7, 112.4, 112.3, 112.1, 112.0, 111.7, 111.6, 55.2, 55.2, 
38.9, 38.4, 36.5, 36.1, 36.0, 35.7, 31.6, 31.0, 27.6, 27.4 ppm (one carbon missing due to overlapping); 
HRMS (ESI): m/z: calcd for C28H24Br2N2NaO+: 585.0147, found: 585.0139. 
 
1-(4-Methoxyphenyl)-4,6-dimethyl-4-(5-methyl-1H-indol-3-yl)-2,3,4,9-tetrahydro-1H-carbazole (3v) 
Obtained as 1:1 diastereomeric mixture. Characterization of a 1:0.78 ratio of diastereoisomers. IR 
(neat, ν/cm-1): 3408, 2962, 2927, 2857, 1507, 1460, 1298, 1240, 1164, 1031, 921, 806, 732, 419; 1H 
NMR (400 MHz, CDCl3): δ = 7.73 (bs, 1H, minor isomer), 7.71 (bs, 1H, major isomer), 7.68 (s, 1H, 
major isomer), 7.43 (s, 1H, minor isomer), 7.36 (s, 1H major, 1H minor), 7.31 (s, 1H, major isomer), 
7.24 (s, 1H, major isomer), 7.22 (s, 1H, minor isomer), 7.13-7.08 (m, 3H major isomer and 4H minor 
isomer), 7.03-6.82 (m, 4H major isomer and 3H minor isomer), 6.75 (d, J = 1.7 Hz, 1H, minor isomer), 
6.57 (d, J = 2.2 Hz, 1H, major isomer), 4.18 (t, J = 6.0 Hz, 1H, minor isomer), 4.07 (dd, J = 10.6, 5.6 Hz, 
1H, major isomer), 3.82 (s, 3H, minor isomer), 3.79 (s, 3H, major isomer), 2.70-2.66 (m, 1H, major 
isomer), 2.50 (s, 3H, major isomer), 2.46-2.42 (m, 1H, minor isomer), 2.39 (s, 3H, minor isomer), 2.34 
(s, 3H, major isomer), 2.29 (s, 3H, minor isomer), 2.18-2.08 (m, 1H, major isomer), 2.10 (s, 3H, major 
isomer), 2.05 (s, 3H, minor isomer), 2.04-1-86 (m, 1H major and 3H minor), 1.78-1.69 (m, 1H, major 
isomer) ppm; 13C NMR (100 MHz, CDCl3): δ = 158.5, 158.4, 136.7, 136.2, 136.1, 135.8, 135.6, 135.4, 
134.5, 134.5, 129.3, 129.2, 129.0, 128.2, 127.9, 127.9, 127.7, 127.7, 127.1, 127.0, 126.0, 125.6, 
124.6, 124.1, 123.7, 122.9, 122.4, 122.3, 120.8, 120.7, 120.6, 120.5, 118.6, 118.1, 114.0, 113.9, 
111.0, 110.8, 110.2, 110.1, 55.3, 55.2, 41.8, 40.2, 38.5, 36.7, 36.6, 35.9, 30.7, 30.5, 29.7, 28.7, 27.9, 
21.7, 21.5, 21.5 ppm; HRMS (ESI): m/z: calcd for C30H30N2NaO+: 457.2250, found: 457.2252. 
 
4-(4-Methoxyphenyl)-1,6-dimethyl-1-(5-methyl-1H-indol-3-yl)-2,3,4,9-tetrahydro-1H-carbazole (3’v) 
Obtained as 1:1 diastereomeric mixture. Characterization of a 1:0.57 ratio of diastereoisomers. IR 
(neat, ν/cm-1): 3405, 2927, 2846, 1611, 1509, 1460, 1300, 1243, 1174, 1031, 908, 795, 732; 1H NMR 
(400 MHz, CDCl3): δ = 7.87 (bs, 2H major and minor isomer), 7.72 (s, 1H, minor isomer), 7.62 (s, 1H, 
major isomer), 7.34 (s, 1H, minor isomer), 7.25-7.21( m, 1H major isomer and 2H minor isomer), 7.19 
(d, J = 8.5 Hz, 2H, major isomer), 7.14 (d, J = 8.2 Hz, 1H, minor isomer), 7.08 (d, J = 8.2 Hz, 1H, major 
isomer), 7.05 (s, 1H, major isomer), 7.00-6.95 (m, 1H, minor isomer), 6.97 (dd, J = 8.3, 1.2 Hz, 1H 
major), 6.91 (dd, J = 8.2, 1.2 Hz, 1H, minor isomer) 6.88 (s, 1H, minor isomer), 6.78 (s, 1H, minor 
isomer), 6.88-6.82 (m, 3H major isomer and 5H minor isomer), 6.69 (s, 1H, major isomer), 4.28 (t, J = 
6.3 Hz, 1H, major isomer), 4.23 (t, J = 6.0 Hz, 1H, minor isomer), 3.82 (s, 3H, major isomer), 3.79 (s, 
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3H, minor isomer), 2.59-2.53 (m, 1H, minor isomer), 2.50-2.45 (m, 1H major isomer and minor 
isomer), 2.36 (s, 3H, minor isomer), 2.30 (s, 3H, major isomer), 2.29 (s, 3H, minor isomer), 2.27 (s, 
3H, major isomer), 2.22-2.14 (m, 1H major and minor isomer), 1.94-1.83 (m, 2H major isomer, 1H 
minor isomer), 1.92 (s, 3H, major isomer), 1.88 (s, 3H, minor isomer) ppm; 13C NMR (100 MHz, 
CDCl3): δ = 157.7, 157.6, 142.1, 141.8, 138.5, 138.2, 135.4, 135.3, 134.2, 134.1, 129.1, 129.0, 128.5, 
128.3, 128.2, 127.9, 127.7, 127.4, 125.6, 125.4, 123.5, 123.4, 122.9, 122.8, 122.7, 122.6, 122.5, 
122.4, 120.5, 120.2, 119.4, 119.4, 113.5, 113.5, 111.0, 110.9, 110.9, 110.8, 110.3, 110.2, 55.2, 55.2, 
39.1, 38.5, 36.2, 36.1, 35.9, 35.8, 31.8, 31.1, 27.9, 27.5, 21.7, 21.5, 21.4, 21.4 ppm; HRMS (ESI): m/z: 
calcd for C30H30N2NaO+: 457.2250, found: 457.2249. 
 
5-(5-Cyano-1H-indol-3-yl)-8-(4-methoxyphenyl)-5-methyl-6,7,8,9-tetrahydro-5H-carbazole-3-carbonitrile (3w) 
Obtained as 1:1 diastereomeric mixture. IR (neat, ν/cm-1): 3316, 2927, 2852, 2218, 1613, 1509, 1469, 
1339, 1310, 1245, 1177, 1033, 908, 807, 731, 647; 1H NMR (400 MHz, CDCl3): δ = 8.63 (s, 1H), 8.49 (s, 
1H), 8.09 (s, 1H), 8.05 (s, 1H), 7.97 (s, 1H), 7.73 (s, 1H), 7.49-7.34 (m, 8H), 7.31 (s, 1H), 7.28 (d, J = 5.4 
Hz, 2H), 7.15 (d, J = 8.5 Hz, 1H), 6.99 (d, J = 8.5 Hz, 2H), 6.94 (d, J = 8.5 Hz, 2H), 6.87 (s, 1H), 4.36 (dd, 
J = 10.1, 5.6 Hz, 1H), 4.20 (dd, J = 8.7, 5.8 Hz, 1H), 3.89 (s, 3H), 3.83 (s, 3H), 2.61-2.58 (m, 1H), 2.55-
2.50 (m, 1H), 2.33-2.30 (m, 1H), 2.23-2.16 (m, 2H), 2.10-2.00 (m, 2H), 2.06 (s, 3H), 2.00 (s, 3H), 1.85 
(dd, J = 22.2, 10.1 Hz, 1H) ppm; 13C NMR (100 MHz, CDCl3): δ = 158.8, 158.7, 139.0, 138.8, 138.3, 
137.8, 137.6, 134.6, 134.5, 129.3, 129.0, 129.0, 128.2, 126.4, 126.3, 126.1, 125.8, 125.7, 125.6, 
125.4, 125.1, 125.0, 124.9, 124.7, 124.6, 124.5, 124.3, 124.2, 123.1, 121.0, 120.9, 120.9, 118.5, 
118.4, 114.4, 114.3, 112.4, 112.3, 111.6, 111.5, 102.0, 102.0, 101.8, 101.6, 55.3, 55.3, 41.2, 40.7, 
39.0, 38.1, 36.1, 34.9, 31.0, 30.0, 28.6, 27.2,  ppm; HRMS (ESI): m/z: calcd for C30H24N4NaO+: 
479.1842, found: 479.1845. 
 
8-(5-Cyano-1H-indol-3-yl)-5-(4-methoxyphenyl)-8-methyl-6,7,8,9-tetrahydro-5H-carbazole-3-carbonitrile (3’w) 
Obtained as 1:1 diastereomeric mixture. Characterization of a 1:0.79 ratio of diastereoisomers. IR 
(neat, ν/cm-1): 3321, 2926, 2857, 2218, 1614, 1509, 1471, 1244, 1176, 1031, 907, 806, 730; 1H NMR 
(400 MHz, CDCl3): δ = 8.48 (s, 1H, minor isomer), 8.42 (s, 1H, major isomer), 8.19 (s, 1H, major 
isomer), 7.91 (s, 1H major and minor), 7.43-7.24 (m, 4H major isomer and 6H minor isomer), 7.21 (d, 
J = 2.1 Hz, 1H, minor isomer), 7.17-7.15 (m, 3H, major isomer), 7.12 (d, J = 8.5 Hz, 2H, major isomer),  
6.94 (d, J = 2.2 Hz, 1H, major isomer), 6.89-6.86 (m, 4H, minor isomer),  4.32 (dd, J = 8.4, 5.9 Hz, 1H, 
minor isomer), 4.23 (t, J = 6.52, 1H, major isomer), 3.84 (s, 3H, minor isomer), 3.80 (s, 3H, major 
isomer), 2.51-2.41 (m, 2H, major isomer), 2.30-2.19 (m, 2H, major isomer), 2.04-1.93 (m, 2H, minor 
isomer), 1.95 (s, 3H, minor isomer), 1.92 (s, 3H, major isomer), 1.87-1.79 (m, 2H, minor isomer) ppm; 
13C NMR (100 MHz, CDCl3): δ = 158.3, 158.2, 143.0, 142.9, 141.6, 141.5, 141.3, 138.8, 138.7, 137.7, 
137.6, 136.9, 136.5, 128.8, 128.7, 127.2, 126.8, 126.1, 125.7, 125.6, 125.3, 125.2, 125.1, 124.9, 
124.8, 124.7, 124.6, 124.1, 123.9, 123.7, 120.9, 120.8, 120.4, 114.1, 113.3, 113.2, 112.4, 112.3, 
111.5, 111.3, 102.9, 102.7, 102.4, 102.2, 55.2, 39.6, 38.5, 37.6, 36.4, 36.2, 35.5, 31.9, 30.9, 27.4, 27.4 
ppm; HRMS (ESI): m/z: calcd for C30H24N4NaO+: 479.1842, found: 479.1840. 
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Analytical data for representative vinyl-cyclopropyl indoles 
 
3-(1-(2-(4-Methoxyphenyl)cyclopropyl)vinyl)-1-methyl-1H-indole (5b) 
IR (neat, ν/cm-1): 3043, 3008, 2927, 2834, 1612, 1512, 1472, 1464, 1244, 1225, 1177, 1103, 1034, 
833, 806, 737, 539; 1H NMR (400 MHz, CD2Cl2): δ = 7.92 (d, J = 8.0 Hz, 1H), 7.34 (d, J = 8.1 Hz, 1H), 
7.25 (t, J = 7.5 Hz, 1H), 7.18-7.12 (m, 4H), 6.89 (d, J = 8.6 Hz, 2H), 5.47 (s, 3H), 5.08 (s, 3H), 3.81 (s, 
3H), 3.72 (s, 3H), 2.07-1.97 (m, 2H), 1.47-1.42 (m, 1H), 1.21 (td, J = 8.6, 5.3 Hz, 1H) ppm; 13C NMR 
(100 MHz, CD2Cl2): δ = 158.5, 143.2, 138.2, 135.5, 128.5, 127.2, 126.5, 122.3, 121.2, 120.3, 117.0, 
114.4, 110.0, 106.2, 55.8, 33.3, 29.3, 25.6, 15.5 ppm; HRMS (ESI): m/z: calcd for C21H22NO+: 304.1696, 
found: 304.1694. 
 
Experimental procedure for allene 6 
TFA (0.186 mmol, 80 mol%) was added to a solution of indole (0.232 mmol, 1.0 eq.) and cyclopropyl 
alkyne (0.232 mmol, 1.0 eq.) in dry toluene (0.1 M). The mixture was heated up to 80 oC and stirred 
until consumption of the starting materials. Then, water was added and extracted with DCM. The 
combined organic layers were dried over anhydrous MgSO4 and the solvent was evaporated under 
vacuum. The residue was purified by flash chromatography (Hexane:EtOAc). 
 
1-Benzyl-3-(1-(4-methoxyphenyl)penta-3,4-dienyl)-1H-indole (6a) 
IR (neat, ν/cm-1): 3048, 2991, 2927, 2898, 2834, 1947, 1609, 1509, 1482, 1466, 1327, 1244, 1175, 
1034, 841, 738, 550; 1H NMR (400 MHz, CDCl3): δ = 7.37 (d, J = 7.9 Hz, 1H), 7.27-7.23 (m, 3H), 7.21-
7.16 (m, 3H), 7.09-7.05 (m, 3H), 6.98-6.93 (m, 2H), 6.77 (d, J = 8.6 Hz, 2H), 5.24 (s, 2H), 5.03 (q, J = 7.0 
Hz, 1H), 4.52-4.49 (m, 2H), 4.23 (t, J = 7.5 Hz, 1H), 3.72 (s, 3H), 2.86-2.78 (m, 1H), 2.69-2.61 (m, 1H)  
ppm; 13C NMR (100 MHz, CDCl3): δ = 209.0, 157.9, 137.8, 136.9, 136.7, 128.9, 128.7, 127.7, 127.5, 
126.6, 125.5, 121.7, 119.7, 118.9, 118.9, 113.6, 109.5, 88.6, 74.4, 55.2, 49.9, 42.2, 35.5 ppm; HRMS 
(ESI): m/z: calcd for C27H25NNaO+: 402.1828, found: 402.1823. 
 
3-(1-(4-Methoxyphenyl)penta-3,4-dienyl)-1-methyl-1H-indole (6b) 
IR (neat, ν/cm-1): 3048, 2991, 2927, 2898, 2834, 1947, 1609, 1509, 1482, 1466, 1327, 1244, 1175, 
1034, 841, 738, 550; 1H NMR (400 MHz, CD2Cl2): δ = 7.38 (d, J = 7.9 Hz, 1H), 7.28 (d, J = 8.2 Hz, 1H), 
7.22 (d, J = 8.6 Hz, 2H), 7.15 (t, J = 7.6 Hz, 1H), 6.97 (t, J = 7.4 Hz, 1H), 6.93 (s, 1H), 6.82 (d, J = 8.6 Hz, 
2H), 5.09 (q, J = 7.0 Hz, 1H), 4.66-4.56 (m, 1H), 4.24 (t, J = 7.6 Hz, 1H), 3.76 (s, 3H), 3.75 (s, 3H), 2.91-
2.83 (m, 1H), 2.74-2.66 (m, 1H) ppm; 13C NMR (100 MHz, CD2Cl2): δ = 209.6, 158.6, 137.8, 137.6, 
129.4, 127.9, 126.6, 122.000, 119.8, 119.1, 118.7, 114.1, 109.7, 89.1, 74.7, 55.7, 42.7, 35.9, 33.1  
ppm; HRMS (ESI): m/z: calcd for C21H21NNaO+: 326.1515, found: 326.1512. 
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9-Benzyl-4-(4-methoxyphenyl)-1-methyl-4,9-dihydro-3H-carbazole (7’a) 
IR (neat, ν/cm-1): 3060, 3025, 2933, 2829, 1608, 1508, 1463, 1452, 1353, 1300, 1245, 1176, 1033, 
830, 740; 1H NMR (400 MHz, Toluene-d8): δ = 7.19 (d, J = 8.6 Hz, 2H), 7.14 (d, J = 8.0 Hz, 2H), 7.04-
6.94 (m, 5H), 6.80 (d, J = 7.0 Hz, 2H), 6.73 (d, J = 8.6 Hz, 2H), 5.44-5.41 (m, 1H), 5.13 (s, 2H), 4.27-4.22 
(m, 1H), 3.33 (s, 3H), 2.68-2.48 (m, 2H), 1.91 (d, J = 1.6 Hz, 3H) ppm; 13C NMR (100 MHz, Toluene-d8): 
δ = 158.8, 139.2, 138.9, 136.4, 129.2, 127.4, 127.2, 126.8, 125.7, 122.1, 120.3, 120.2, 114.1, 109.7, 
54.6, 48.2, 38.9, 35.1 ppm; MS (ESI): m/z [M+1]+ = 380.2. 
 
1-(4-Methoxyphenyl)-4,9-dimethyl-2,9-dihydro-1H-carbazole (7b) 
IR (neat, ν/cm-1): 3051, 2999, 2929, 2858, 2837, 1609, 1508, 1461, 1451, 1365, 1301, 1240, 1175, 
1033, 829, 738, 549; 1H NMR (400 MHz, CD2Cl2): δ = 7.29 (d, J = 8.3 Hz, 1H), 7.17-7.15 (m, 2H), 7.10 
(ddd, J = 8.2, 6.6, 1.5 Hz, 1H), 6.94-6.87 (m, 1H), 6.81-6.79 (m, 2H), 5.68 (dt, J = 4.8, 1.6 Hz, 1H), 4.22 
(t, J = 8.0 Hz, 1H), 3.92 (s, 3H), 3.77 (s, 3H), 7.79-7.71 (m, 1H), 2.57-2.49 (m, 1H), 2.32 (d, J = 1.7 Hz, 
3H) ppm; 13C NMR (100 MHz, CD2Cl2): δ = 158.8, 138.8, 137.7, 137.2, 129.3, 129.3, 127.9, 126.3, 
124.7, 121.6, 119.7, 119.4, 114.1, 109.6, 55.7, 38.3, 34.9, 32.6, 21.2 ppm; HRMS (ESI): m/z: calcd for 
C21H21NNaO+: 326.1515, found: 326.1512. 
 
4-(4-Methoxyphenyl)-9-methyl-1-methylene-2,3,4,9-tetrahydro-1H-carbazole (7’b) 
IR (neat, ν/cm-1): 3056, 2999, 2932, 2832, 1723, 1609, 1508, 1464, 1367, 1240, 1174, 1035, 830, 744, 
710, 554; 1H NMR (400 MHz, CD2Cl2): δ = 7.31 (d, J = 8.3 Hz, 1H), 7.17-7.13 (m, 1H), 7.09 (d, J = 8.6 
Hz, 2H), 6.87-6.84 (m, 2H), 6.82-6.79 (m, 2H), 5.38 (s, 1H), 5.16 (s, 1H), 4.32 (t, J = 6.4 Hz, 1H), 3.91 (s, 
3H), 3.77 (s, 3H), 2.66-2.59 (m, 1H), 2.37-2.29 (m, 1H), 1.96-1.88 (s, 1H) ppm; 13C NMR (100 MHz, 
CD2Cl2): δ = 158.7, 139.8, 138.7, 138.6, 135.6, 129.5, 126.6, 122.9, 120.5, 119.4, 116.8, 114.1, 109.6, 
108.6, 55.7, 40.2, 36.2, 33.6, 32.8 ppm; HRMS (ESI): m/z: calcd for C21H21NNaO+: 326.1515, found: 
326.1513. 
 
9-Benzyl-1-(4-methoxyphenyl)-4-methyl-4-(1-methyl-1H-indol-3-yl)-2,3,4,9-tetrahydro-1H-carbazole (9) 
Obtained as 1:1 diastereomeric mixture. Characterization of a 1:0.70 diastereomeric ratio. IR (neat, 
ν/cm-1): 3046, 2926, 2858, 1603, 1509, 1462, 1453, 1374, 1327, 1244, 1176, 1031, 908, 832, 806, 
734, 699, 561; 1H NMR (500 MHz, CDCl3): δ = 7.72 (d, J = 8.0 Hz, 1H, minor isomer), 7.66 (d, J = 8.0 
Hz, 1H, major isomer), 7.54 (d, J = 7.9 Hz, 1H, major isomer), 7.46 (d, J = 7.9 Hz, 1H, minor isomer), 
7.30-6.75 (m, 15H major isomer and 16 H minor isomer), 6.44 (s, 1H, major isomer), 5.17-5.13 (m, 
1H, major and minor isomer), 4.80-4.76 (m, 1H, major and minor isomer), 4.02 (dd, J = 5.5, 2.7 Hz, 
1H, major isomer), 3.99 (t, J = 5.8 Hz, 1H, minor isomer), 3.81 (s, 3H, major isomer), 3.76 (s, 3H, 
minor isomer), 3.71 (s, 3H, minor isomer), 3.64 (s, 3H, major isomer), 2.41-2.36 (m, 1H, minor 
isomer), 2.34-2.30 (m, 1H, major isomer), 2.27-2.21 (m, 1H, minor isomer), 2.14 (s, 3H, major 
isomer), 2.11-2.05 (m, 1H, major isomer), 2.03 (s, 3H, minor isomer), 2.00-1.95 (m, 1H, minor 
isomer), 1.94-1.89 (m, 1H, major isomer), 1.81-1.76 (m, 1H, minor isomer), 1.68-1.64 (m, 1H, major 
isomer) ppm; 13C NMR (125 MHz, CDCl3) (major and minor isomer): δ = 158.1, 158.1, 138.4, 138.3, 
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137.9, 137.8, 137.4, 137.4, 136.5, 136.4, 136.2, 136.0, 129.1, 128.8, 128.6, 128.6, 128.5, 128.3, 
127.8, 127.7, 127.1, 126.9, 126.5, 126.4, 126.3, 126.3, 126.1, 126.0, 125.9, 123.3, 122.5, 121.3, 
121.1, 120.8, 120.8, 120.7, 119.6, 119.3, 118.6, 118.5, 118.1, 118.0, 113.8, 113.8, 109.3, 109.3, 
109.2, 109.2, 55.2, 55.2, 46.5, 46.3, 37.9, 36.7, 36.5, 36.4, 34.5, 32.6, 32.6, 31.1, 30.1, 29.7, 29.2, 28.2 
ppm (one carbon is missing due to overlapping); HRMS (ESI): m/z: calcd for C36H34N2NaO+: 533.2563, 
found: 533.2563. 
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